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Magnetic resonance imaging (MRI) reporter genes produce MRI signal in response to the 
molecular environment of the cells in which they are expressed. With an MRI scanner, 
the signal is detected and used to produce an image of the cells. We hypothesized that the 
magnetotactic bacterial gene mms6 has the potential to function as an MRI reporter gene. 
Magnetotactic bacteria produce magnetic iron oxide crystals in intracellular organelles 
called magnetosomes. mms6 encodes an iron-binding, magnetosome membrane protein 
Mms6, which plays a role in regulating the size and shape of the iron oxide crystals found 
within the magnetosomes. To test our hypothesis, several mammalian cell lines were 
transfected with mms6, and mms6-positive clones were genetically engineered. We then 
used MRI to image these clones in vitro. When the cells were incubated with iron-
supplemented culture media, the mms6-positive clones produced more MRI image 
contrast than mms6-negative cells. Through a systematic process of elimination, the 
mms6-positive clone that generated the most in vitro MRI image contrast was identified. 
This clone, named 9L4S, was composed of mms6-positive rat glioma (9L) cells and was 
used for intracellular iron studies and in vivo imaging. The results of electron microscopy 
and optical emission spectrometry support the theory that mms6-positive clones enhance 
MRI image contrast due to an increase in intracellular iron. The main objective of this 
research was to assess the ability of mms6 to function as an in vivo MRI reporter gene, so 
a flank tumor animal model was created. Without any exogenous iron supplementation, 
tumors composed of mms6-positive cells produced greater negative contrast on an MRI 
image than mms6-negative cells. These results demonstrate that mms6 can be considered 








Magnetic resonance imaging (MRI) is a non-invasive imaging modality that is widely 
and commonly used in clinical and research settings. In a clinical setting, MRI is most 
often used by radiologists to image the inside of the human body and by clinicians to 
diagnose and track the progression of injury and disease in patients. In a research setting, 
MRI is a powerful piece of equipment used to conduct experiments. Advancements in 
MRI technology and the development and improvement of MRI-based applications are 
an ongoing part of MRI research. One such application is called molecular MRI, which is 
focus of the research presented in this dissertation.  
 
Molecular MRI is the imaging of cellular and molecular events with MRI. One of the 
current focuses of preclinical research is on examining the limitations and possible 
applications of molecular MRI. In order for molecular MRI to be effective, it will have to 
be capable of determining the location, distribution, and long-term viability of an in vivo 
cell population and capable of providing spatial and temporal information on subcellular 
biological processes such as those involving proteomic, genetic, metabolic, and 
enzymatic changes (1, 2). In an effort to push the limits of molecular MRI, several 
methods of labeling cells and tracking them in vivo with MRI have been explored—the 
transfection of cells with an MRI reporter gene is one such method. MRI reporter genes 
make it possible for cells expressing the gene to enhance their MRI image contrast, or to 
put it another way, to stand out from the surrounding tissue in an MRI image. An 
assortment of distinct types of MRI reporter genes have been developed, such as 
chemical exchange saturation transfer (CEST)-based, iron-based, and enzyme-based 
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reporter genes (3); however, to date, none of these reporter genes have come into 
widespread use. In fact, aside from the original studies reporting on the development of 
novel reporter genes, very few of these studies have led to follow-up research, neither by 
the group that originally pioneered the work nor by another research group (4). The lack 
of significant progress is a reflection of the limitations associated with the use of MRI 
reporter genes (4). Some of disadvantages of using MRI reporter genes are related to the 
inherent limitations of MRI technology. For example, due to the low sensitivity of MRI, a 
down-side of using the lysine-rich protein (LRP)-based reporter gene is the need to use 
high-field magnets for signal detection (5). The low sensitivity of MRI also makes it a 
requirement for any MRI reporter gene to be able to produce significant amount of MRI 
signal in order to generate enough image contrast. Some of the limitations are specifically 
related to the particular design of a specific reporter gene. For instance, iron-based 
reporter genes require a certain amount of iron to produce contrast—iron that may not be 
readily available. There are also practical limitations; successfully expressing reporter 
genes in vivo can be very time consuming and technically challenging. As a consequence 
of these limitations and others not listed here, the development of MRI reporter genes 
continues to be in its early stages.  
 
Developing an MRI reporter gene is important because MRI reporter genes are powerful 
tools that could be utilized in a wide variety of applications. Insights into the workings of 
the human body can be gained by using MRI to visualize and characterize biological 
processes in living subjects. With MRI reporter genes, biological processes can be 
studied at the molecular level; so despite all the limitations discussed above, progress in 
the development of MRI reporter genes will continue as long as the possibility remains 
that an MRI reporter gene capable of overcoming those limitations can be synthesized or 
discovered. With a need in the molecular imaging field for a better and novel MRI 
reporter gene, this dissertation describes our efforts to find such a gene. When we began 
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our study, we searched for a gene that meets our standards of what constitutes a “good” 
MRI reporter gene. We agree with Gilad et al. who wrote, “As to what the ideal MRI 
reporter gene would be, … it would encode endogenous intracellular accumulation of the 
most sensitive MRI label to date, i.e. superparamagnetic iron oxide (SPIO) particles” (4). 
With this criterion in mind, we focused our attention on magnetotactic bacterial genes 
because magnetotactic bacteria have intracellular organelles containing iron oxide. As 
discussed in more detail in Chapter 2, we ended up selecting the magnetotactic bacterial 
gene mms6 for our research. This dissertation delineates the study of the gene mms6 after 
it was transfected and expressed in mammalian cells for the purpose of developing and 





The objective of the research was to assess the possibility of mms6 functioning as an in 
vivo MRI reporter gene. To make that assessment, mms6 needed to be expressed in vivo 
to determine whether or not its expression would enhance MRI contrast in situ. In order 
to accomplish this goal, we set out to complete the three aims that are listed below and 
that are described in greater detail in Chapters 2, 3, and 4 of this dissertation.  
 
1.1.1 Aim 1: Selection of a gene and creation of positive clones. 
 
Because MRI reporter genes encode proteins that are able to enhance MRI contrast, we 
searched the literature for a gene that encodes a protein that could reasonably be expected 
to enable cells expressing that protein to take up iron, which is a known negative contrast 
agent. As mentioned above, we selected a potential MRI reporter gene out of the pool of 
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genes expressed solely in magnetotactic bacteria. We ended up selecting two genes for 
analysis, magA and mms6; the former was thought to encode an iron transport protein and 
the latter encodes an iron-binding protein. Several mammalian cell lines, which will 
subsequently be referred to as wild-type cells or negative cells since they do not express 
the transgene, were transfected with the transgenes and antibiotic resistance genes to 
create the stable clones. Because we wanted to perform MRI experiments that would last 
for several weeks, the objective was then to create several stable clones expressing either 
magA or mms6, referred to as positive clones. Stable clones are able to express the 
transfected genes for at least several months. Using standard cell cloning techniques, 
positive clones were genetically engineered.  
 
After the clones were generated, the main objective was to identify the clone that 
generated the most in vitro MRI contrast because that clone would be the best candidate 
for in vivo MRI studies. Because growing enough cells for imaging is time consuming 
and requires the use of a lot of media and cell culture dishes, a faster and easier 
systematic selection process was used to identify the clone that produced the most MRI 
contrast. We hypothesized that the clone that would produce the most negative contrast 
would also be the clone with the greatest intracellular iron content, so we used a Prussian 
blue staining assay, a qualitative technique, as a screen to select the clone with the 
highest iron content. The clones with the greatest levels of intracellular iron were then 
tested to confirm that they contained the transgene and that they expressed the protein. 
Clones that tested positive for the transgene were imaged in vitro with MRI at 3 tesla (T). 
Only mms6 was found to alter the MRI contrast of the host cell line. As expected, the 
positive clones generated more MRI contrast than control cells.  
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1.1.2 Aim 2: In vitro MRI and examination of intracellular iron. 
 
Because the creation of a tumor animal model was the main objective of Aim 3, the in 
vitro experiments focused on a positive clone derived from immortalized gliosarcoma 
cells called 9L cells, a cell line capable of growing tumors in vivo. Choosing only from 
among positive clones derived from 9L cells, the positive clone that generated the most 
MRI contrast relative to negative cells was named 9L4S. The 9L4S clone was selected 
for further study. We began by measuring the MRI contrast of the cells at 3 T and 9.4 T. 
Next, the mms6-positive clone 9L4S and its respective wild-type cell line, 9L cells, were 
sent to a lab that used inductively coupled plasma optical emission spectrometry (ICP-
OES), a quantitative technique, to measure their iron contents and to support the results 
of the Prussian blue staining assay. The results confirmed that the mms6 positive clone 
contained significantly more iron and produced more image contrast than the wild-type 
cells.  
 
1.1.3 Aim 3: Establishment of an animal model and in vivo MRI. 
 
Since the in vitro results showed that 9L4S cells have faster relaxation rates than 9L cells, 
we used an animal model to determine whether the 9L4S clone can also enhance contrast 
in vivo. This final objective was important because MRI reporter genes need to be able to 
create contrast in vivo to be versatile research tools. We created a flank tumor model with 
rats by injecting 9L and 9L4S cells into the flank. As the cells divided, a tumor formed. 
After 9L and 9L4S tumors were established, the tumors were imaged in situ in a small 
animal 9.4 T MRI scanner. Because 9L4S cells had already been found to have faster 
relaxation rates than 9L cells in vitro, we hypothesized that the relaxation rates of 9L4S 
tumors would also be faster than the relaxation rates of 9L tumors. The results supported 
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our hypothesis but only in small tumors. If too many cells were used to inoculate tumors 
so that the tumor became larger in a shorter amount of time or if too much time was 
allowed to pass so that the tumors had more time to grow, the opposite of what we 
expected happened: the relaxation rates of 9L4S tumors were slower than the relaxation 
rates of 9L tumors. Not only did we expected to see 9L4S tumors produce more contrast, 
but we also expected them to contain more iron than 9L tumors; so after imaging, the 
tumors were excised and prepared for histological staining of iron content with Prussian 
blue. When the 9L4S tumors had faster relaxation rates than 9L tumors, the results 





In this subsection, useful information is provided to enable the reader to obtain a more 
thorough understanding of the field of molecular imaging and MRI. The knowledge 
provided here will also allow the reader to better comprehend the basis of the 
experimental design presented in the subsequent chapters. 
 
1.2.1 Molecular Imaging and Cell Labeling 
 
Molecular imaging is the noninvasive and in vivo visualization and characterization of 
cellular and molecular events involved in biological processes, both biological and 
pathological (6, 7). A biological process, such as cell division and apoptosis, often 
involves many types of biomolecules, including genes, ions, enzymes, ligands and 
receptors, as well as other proteins. Visualization of cellular and molecular events entails 
visualizing these biomolecules. Any of these molecules may be analyzed, in theory, with 
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molecular imaging; however, because of the relative novelty of the MRI molecular 
imaging field as well as the low sensitivity of MRI, in practice, the objective of molecular 
MRI studies has been not to examine the activity of the biomolecules themselves but to 
examine the MRI contrast produced by cells. The greater the MRI contrast, the easier it is 
to visualize and study the cells. To enhance the level of MRI contrast produced in situ by 
a cell type of interest relative to the MRI contrast of the surrounding tissue, the cells can 
be labeled. For instance, if an oncologist was interested in tracking the metastasization of 
cancer cells, better visualization of the cancer cells could be achieved if the cells were 
labeled. In MRI, a label is used to alter the MRI contrast produced by a cell or 
biomolecule. Although a wide variety of unique methods to label cells have been 
developed, detection methods of in vivo cells can be divided into two major categories 
depending on their routes of labeling: one is called exogenous labeling and the other is 
called endogenous labeling, or direct and indirect labeling, respectively. Exogenous 
labeling is the tagging of cells with a label that originated ex vivo. Endogenous labeling is 
the tagging of cells with a label that originated in vivo. 
 
Exogenous labeling often involves the ex vivo coupling of a label to a molecule, such as a 
transfection agent or a positively charged peptide. When the label must be transported 
into cells in order to function, the molecule facilitates the binding or crossing of the cell 
membrane. Once the label and the molecule are coupled, the label is ready for transport. 
To reach the cells of interest, the label must be designed so that when it is administered to 
a living recipient, the label has the means to reach and bind the target cells (2, 8). For 
example, a label may be designed to express a specific ligand that is able to bind 
exclusively to receptors on specific cells; and if that ligand were injected intravenously, it 
would travel throughout the body until it reached the target cells. When that label reached 
the target cells, it would bind the cell membranes and would be transported into the target 
cells. As an alternative to the approach just described, cells may be labeled in vitro 
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instead of in vivo by tagging the cells with labels ex vivo (2, 8). If that were the case, the 
pre-labeled cells, instead of the just the label, would be administered to the recipient. 
Regardless of the specific method used, once labeled, the cells are ready for MRI.  
 
In contrast to the exogenous labeling of cells, endogenous labeling often involves genetic 
modification of the cells of interest (2). In the case of magnetic resonance imaging, to 
label them, cells must be transfected with MRI reporter genes. The reporter gene may 
code for a receptor, a fluorescent protein, an enzyme, or one of several other molecules. 
When the reporter gene is expressed in a cell, the end result is that the contrast produced 
by the cell of interest is enhanced such that transfected cells are more easily seen in an 
MRI image compared to cells that do not express the reporter gene. At the molecular 
level, the exact chain of events that leads to the production of detectable MRI contrast 
depends on the specific reporter gene used.  
 
Several different MRI reporter genes have been developed, each with their own unique 
mode of action. What they all have in common is that once any of the reporter genes are 
expressed in cells, the gene product, i.e. a protein or functional RNA, either directly 
produces MRI contrast or sets off a chain of molecular events that result in the activation 
or accumulation of the label or imaging probe, i.e. the molecule or particle that produces 
the MRI contrast. Several strategies have been used to enhance the MRI contrast 
produced by cells. Louie et al. used the enzyme galactosidase to cleave and thus activate 
a gadolinium-based substrate. Once activated, gadolinium increased the T1 signal (9). 
Cohen et al. overexpressed ferritin, an iron-storage gene, in cells to shorten their T2 
relaxation times (10). As a final example, Gilad et al. designed a lysine-rich protein 
(LRP) reporter, expressed LRP in glioma cells, and then used those LRP-positive cells to 
establish a brain tumor in a mouse. They then selectively labeled the protons of LRP with 
radio frequency irradiation. Finally, the labeled protons of the LRP exchange with the 
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protons of the surrounding water, and due to the process of chemical exchange saturation 
transfer (CEST), endogenous contrast is produced (5). 
 
1.2.2 Basic Principles of MRI 
 
Several imaging techniques are employed for molecular imaging, including MRI, 
positron emission tomography (PET), bioluminescence imaging (BLI), fluorescence 
imaging, single photon emission computed tomography (SPECT), and x-ray and 
ultrasound based method; and each imaging modality is associated with its own 
advantages and limitations. MRI, for instance, provides a non-invasive method for deep 
tissue imaging. MRI can be used to take an image in any orientation in space and to 
provide two and three dimensional data. Because it provides soft tissue contrast at a 
reasonably high spatial resolution, it is especially useful in the detection and 
characterization of solid malignant tumors and other soft tissue pathologies (11). In 
addition, MRI functions with the use of nonionizing radiation, so it is possible to use 
MRI to safely track the progression of a disease or treatment over time (12). Along with 
those advantages, MRI comes with one major limitation: an inherently low sensitivity. 
Despite this drawback, MRI continues to be one of the most important diagnostic 
imaging modalities, and that is unlikely to chance considering the advances in MRI 
technology being made and the increasing number of new clinical applications being 
developed. Considering that thoroughly covering the subject of MRI is beyond the scope 
of this text, only a simplified explanation of MRI will be presented here. 
 
1.2.2.1 Nuclear Spin and MRI 
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All matter in the universe is made up of atoms; and in turn, atoms are composed of three 
subatomic particles: electrons, protons, and neutrons. These three subatomic particles 
have characteristic physical properties. In addition to mass and electric charge, these 
three subatomic particles have an intrinsic physical property called spin. Spin, a quantum-
mechanical property, is a type of angular momentum. It comes in multiples of ½, 
including 0, and can be positive (+) or negative (–). Subatomic particles with non-zero 
spin also have magnetic properties. 
 
MRI is an imaging modality that takes advantage of the magnetic properties of atomic 
nuclei to produce images. Only nuclei with non-zero spin have the magnetic property 
required for MRI. Although workarounds exist, generally speaking, MRI cannot be used 
to image objects composed of atoms or elements with spin 0. Elements with spin 0 
include any element containing an even number of protons and an even number of 
neutrons, such as 16O and 12C (13). Interestingly, almost every element in the periodic 
table has an isotope that does have a non-zero spin; however, the natural abundance of 
each isotope in general and the biological abundance in particular limit the number of 
nuclei that can be imaged using MRI (14). 
 
MRI of the human body is possible because the human body is composed mostly of fats 
and water, both of which contain hydrogen atoms. In fact, it turns out that hydrogen 
makes up approximately 63 percent (%) of all the atoms in the human body (14). Not 
only is it abundant, hydrogen also has one proton in its nucleus, and that proton has a spin 
equal to ½. In other words, hydrogen has spin ½. Nuclei with spin produce a nuclear 
signal that can be detected with an MRI scanner and which can be used to produce an 
image. From now on, this nuclear signal with be referred to as the nuclear magnetic 
resonance (NMR) signal. Because the spin of a nucleus produces an NMR signal 
detectable with an MRI scanner, the presence of hydrogen in large quantities makes the 
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human body a good candidate for MRI. Even so, MRI cannot be used to image the entire 
human body because not all tissues are composed of atoms with non-zero spin. As one 
notable example, MRI cannot be used to image the bones in the human body.  
 
1.2.2.2 Quantum Energy States 
 
So far, it has been established that MRI requires a non-zero spin to produce an MRI 
image. The key to understanding the relationship between nuclear spin and MRI is 
knowing that non-zero nuclear spins are able to interact with the external magnetic fields 
that exist in an MRI scanner. In the discussion that follows, the focus will be on the spin 
of the hydrogen nucleus, or the proton. Understanding how the proton’s spin interacts 
with external magnetic fields will help elucidate in greater detail how MRI works.  
 
Though magnetic charges do not actually exist, a proton’s spin can be better understood 
if it is likened to a pair of magnetic charges of equal magnitudes but opposite signs. Due 
to their polarity, the magnetic charges would form a magnetic field. Thus, spin can be 
pictured as a very small bar magnet with a north pole and a south pole. Normally, spin is 
randomly oriented in space, and it is free to rotate in any direction. Because it is 
polarized, when a spin is placed in the magnetic field of a larger, external magnet; the 
small magnet rotates such that it lines up with the magnetic field. The tiny magnet lines 
up with the larger magnet in one of two configurations, parallel alignment or anti-parallel 
alignment (Figure 1) (13). In the parallel alignment, the north pole of the smaller magnet 
faces the same direction as the north pole of the larger magnet. When the opposite 
occurs, the magnets are said to be in an anti-parallel alignment: the north pole of the 
smaller magnet faces the same direction as the south pole of the larger magnet. Out of 
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Given a group of proton located in an external magnetic field, not all of the protons will 
be in the same energy state; some of the protons will have spins in the high energy state, 
and the remaining protons will have spins in the low energy state (14). Moreover, over 
time, spins can switch back and forth between energy states. Spin in a low energy state 
can absorb energy to move into a high energy state, and spin in a high energy state can 
release energy to move into a low energy state. The amount of energy required by nuclear 
spins to move between energy states is called the quantum energy difference (∆ ). The 
relationship between the quantum energy difference of the nuclear spin and the static 
external magnetic field strength ( ) is given by the equation:  
 




where  is Planck’s constant (  = ~6.626 10-34 J s), and  is a constant called the 
gyromagnetic ratio. The unit of energy is the joule (J). The strength of a magnetic field is 
measured in the unit tesla (T), and the unit of the gyromagnetic ratio is 
radian/second/tesla (rad/s/T). While it is a constant, the value of the gyromagnetic ratio 
depends on the nuclei being subject to the external magnetic field. For example, in water, 
the hydrogen nuclei has a gyromagnetic ratio of approximately 2.68 108 rad/s/T (13). 
Notice that for a given nucleus, with increasing magnetic field strength, the energy 
necessary for nuclear spins to change between energy states increases proportionally. 
Note that Equation (1) and all remaining equations from this chapter are from Reference 
(13), unless otherwise noted. 
 
1.2.2.3 Nuclear Spin and NMR Signal 
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So far, it has been established that nuclei have an intrinsic property called spin that can be 
viewed as a tiny magnet. That tiny magnet can either line up parallel to or anti-parallel to 
an external magnetic field. Of importance, the strength of the NMR signal detected by an 
MRI scanner is dependent on the number of spins in each spatial orientation. The exact 
relationship between the NMR signal and the two possible spin alignments will now be 
explored. 
 
 If ↑  and ↓  are the number of spins in a volume parallel to and anti-parallel to the 
external magnetic field , respectively, then the total number of spins in that volume ( ) 
is given by the following equation: 
 
↑ ↓  (2) 
 
Furthermore, the spin density ( ) of that volume is defined as the number of spins ( ) 
per unit volume ( ): 
 
	 	  
(3)  
 
Given a group of protons inside a homogenous isochromat, or a volume in which all spins 
inside that volume experience the same external magnetic field, the difference between 
the number of spins parallel to and anti-parallel to the external magnetic field as a 









where  is the temperature in kelvin (K), and  is the Boltzmann constant (  = 1.38 10-
23 J/K).  is the average thermal energy, a type of energy associated with the 
temperature of the volume in which the spins are located. Combining Equation (1) with 









At human body temperature, the average thermal energy ( ) is millions of times greater 
than the quantum energy difference (∆ ) (13), which means that the expression on the 
right hand side of Equation (5) is approximately zero and that Equation (5) reduces to: 
 
↑ 	≅ 	 ↓  (6) 
 
According to Equation (6), at human body temperature, the number of spins parallel to an 
external magnetic field is approximately equal to the number of anti-parallel spins. This 
fact is significant because the strength of the NMR signal required to form an MRI image 
is proportional to the relative spin excess, which is the difference between the number of 
spins in parallel-alignment and the number of spins in antiparallel alignment divided by 
the total number of spins. The relationship between the relative spin excess and the NMR 
signal is given by the following equation (14): 
 





If ↑  equaled ↓ , then the NMR signal would be zero. Fortunately, the number of 
spins parallel to the external magnetic field slightly exceeds the number of spins anti-
parallel to the external magnetic field at room temperature (14). For example, noting 
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Equation (4), at 0.3 T and 300 K (~80 ºF), the right hand side of Equation (7) equals 
~1/106. In other words, if the total number of spins equaled 1 million, then ↑ ↓  
would equal ~1. Detecting the signal produced by one spin out of a million spins is not as 
improbable as it sounds because the strength of the NMR signal also depends on the spin 
density of the sample producing the signal. For instance, N	is on the order of 1023 spins in 
just a few grams of body tissue (13).  
 
1.2.2.4 Precession of Nuclear Spin 
 
Although it is not impossible to detect the NMR signal produced by a group of spins at 
room temperature placed in static (not changing over time) and uniform (not varying in 
space) external magnetic field, increasing the NMR signal is necessary to produce high 
quality MRI images. In short, an assortment of magnetic fields is utilized to manipulate 
nuclear spins such that the spins end up producing a stronger NMR signal. To explain 
how spins are manipulated to improve NMR signal, it is first necessary to explain how 
external magnetic fields affect the way spins move.  
 
Spin can be likened to a tiny charge spinning about an axis called the spin axis. Because 
circulating charges produce an electric current, instead of thinking of spin as a tiny 
magnet, spin can be thought of as current loop in which the effective electric current is 
moving around the spin axis (13). As dictated by Ampere’s law, an electric current 
produces a magnetic field; so spin, regardless of whether it is pictured as a tiny spinning 
charge or a tiny bar magnet, is associated with its own small, magnetic field. 
 
In magnetic resonance imaging, an object is placed in the scanner’s magnetic field, which 
is the same as stating that the nuclei of the atoms that make up that object are placed in an 
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external magnetic field. The nuclear spins, having a magnetic field of their own, interact 
with the external magnetic field. To better understand how the two fields interact, it is 
best to represent external magnetic fields, nuclear spins, and the space in which they 
interact mathematically. A magnetic field has both a magnitude and a direction; so 
mathematically, it is represented as a vector quantity. By convention, the magnetic field 
vector ( ) points from the magnetic field’s south pole to its north pole. Because of its 
magnetic properties, spin is represented by a magnetic dipole moment vector (μ), or 
simply a magnetic moment vector. Using the current loop analogy, imagine that the 
current loop, whose current revolves around the spin axis, lies entirely in a plane 
perpendicular to that spin axis. The magnetic moment vector lies perpendicular to and 
through the center of that loop. In other words, the spin axis and the magnetic moment 
vector are coincident. To understand in which direction μ points, image the current loop 
lying in the x-y plane of a three-dimensional (3D) Cartesian coordinate system with an x, 
y, and z-axis. If it were viewed from above the positive z-axis, then the right-hand rule 
would dictate that current traveling clockwise would produce a magnetic moment vector 
pointing in the direction of the positive z-axis. Conversely, current traveling 
counterclockwise would produce a magnetic moment vector pointing in the direction of 
the negative z-axis. Using the bar magnet analogy, just as with the external magnetic field 
( ), μ points in the direction of the south pole to the north pole. Since spin and external 
magnetic fields can be represented mathematically as vectors, the space in which  and μ 
interact can be represented by graphing the vectors in a 3D Cartesian coordinate system. 
 
As discussed previously, when a nuclear spin is placed in an external magnetic field such 
as the one found in an MRI scanner, the spin orients itself parallel to or anti-parallel to 
the field. Although the spins do orient themselves with respect to the field, thermal 



































de ( ) and
 lies in the 
 z-axis.  
ovement o
netic field.
r μ 	(a) lie
kwise direc





 points in th
y-z plane, b
f a magne
 In the prese
s at an angl
tion, and (c







ut μ could h
tic moment
nce of an e






d μ will now









rque on a 
	  
 be depicte






-axis at a r
 in the very 
magnetic m
d on a Cart
he z-axis, a
gure 2a): 






















when  and μ are spatially oriented as shown in Figure 2, the external magnetic field 
causes the magnetic moment vector to precess around the positive z-axis (Figure 2b). 
Thus, the movement of nuclear spin can be likened to that of a gyroscope (13). If one 
were to look down from above the positive z-axis in the Cartesian coordinate onto the x-y 
plane, the magnetic moment vector of a parallel spin (as depicted in Figure 2b, it has a 
positive y-component ( μ ) and a positive z-component ( μ )) would precess clockwise 
around the positive z-axis (Figure 2b). In contrast, the magnetic moment vector of an 
anti-parallel spin (if it was drawn in Figure 2, it would have a positive y-component 
( μ ) and a negative z-component ( μ )) would precess around the negative z-axis. If 
one were to look down from above the negative z-axis onto the x-y plane, the magnetic 
moment vector would precess counterclockwise around the negative z-axis.  
 
As the magnetic moment vector precesses, the path taken by the tip of the vector is a 
circle. In a very short amount of time , the tip travels a very short angular distance 
around the circle ( ) (Figure 2c). By definition, the angular velocity (  of a magnetic 
moment vector precessing around the z-axis is given by the following equation: 
 
	 ≡ 	  
(10)  
 
When placed in an external, static magnetic field of strength , such as the one in the 
MRI scanner, the precession angular frequency is given by: 
 
	  (11) 
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Recall that γ is a constant called the gyromagnetic ratio and that different nuclei have 
different gyromagnetic ratios.  is commonly referred to as the Larmor frequency or the 
resonance frequency. The dependency of the frequency on the gyromagnetic ratio 
confirms what is observed in the laboratory: identical nuclei have the same resonance 
frequency, and distinct nuclei have different resonance frequencies. The unit of frequency 
is called the hertz (Hz), which is equal to one cycle per second (1/s). In MRI, the 
resonance frequency ranges from 0.03 to 3 104 megahertz (MHz), which are radio 
frequencies (13). As Equation (11) indicates, the stronger the magnetic field, the faster 
the precession frequency. For example, a hydrogen proton has a precession frequency of 
~128 MHz at 3 T and a precession frequency of ~400 MHz at 9.4 T.  
 
Briefly returning to the topic of quantum energy states, considering Equation (1) and 
Equation (11), the relationship between the quantum energy difference of the proton spin 







In this equation, the unit of resonance frequency ( ) is rad/s. As Equation (12) indicates, 
the energy required by a spin to transition between energy states increases as the 
resonance frequency increases. In other words, the faster a group of protons are 
precessing, the larger the difference between the energy of spin parallel to the external 
magnetic field and the energy of spin anti-parallel to the external magnetic field. 
 
1.2.2.5 Magnetization and NMR Signal 
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Though a static magnetic field causes nuclear spins to precess, spin movement must be 
further manipulated to maximize the NMR signal that is used to create MRI images. To 
briefly elaborate, an MRI image is created using the signal detected by the MRI scanner. 
The stronger the signal received, the better the image created. The NMR signal is 
associated with spin movement, so manipulating spin movement affects the NMR signal. 
Spin movement is altered by changes in the external magnetic field. In an MRI scanner, 
the external, static field is always turned on, but additional magnetic fields are also used 
to manipulate spins. During the course of an MRI scan, an assortment of magnetic fields 
are used and they are not all turned on and off at the same time. When more than one 
magnetic field is turned on, spins simultaneously feel the combined effects of all the 
magnetic fields. The first magnetic field to be turned on is the radio frequency (rf) field 
( ). The use of  during an MRI scan is usually referred to as an rf pulse because  is 
only on for a very short period of time. To explain how the rf pulse is used to manipulate 
spin movement in order to maximize NMR signal, magnetization vectors need to be 
introduced. 
 
So far, the precession of nuclear spin in a magnetic field has been described. From now 
on, the focus will shift to looking at the net movement of a group of nuclear spins, 
specifically proton spins. To begin, consider an isochromat, which by definition is filled 
with spins experiencing the same external magnetic field. In practice, instead of a 
theoretical homogenous isochromat, a voxel refers to a volume element small enough that 
to a good approximation the external fields are constant over that volume (13). Because 
each spin in a homogeneous isochromat can be represented as a magnetic moment vector, 
the sum total of all the individual magnetic moment vectors (μ ) in that small volume ( ) 









Magnetization, or the magnitude of , is the local magnetic moment vector per unit 
volume. The magnetization is proportional to the relative spin excess, ↑ ↓ /	  
(14). Considering that  is the sum of all the precessing magnetic moment vectors and 
that parallel spins outnumber anti-parallel spins,  also precesses clockwise around an 
external magnetic field pointing in the direction of the positive z-axis at the resonance 
frequency. Furthermore, considering that each magnetic moment vector is associated with 
a tiny magnetic field, the magnetization vector is also associated with its own magnetic 
field.  
 
Notably, the precession of the magnetization vector produces the signal detected in the 
laboratory during an MRI scan. In short, during an MRI scan, as the magnetization vector 
precesses in response to the external magnetic field acting on it, its own internal magnetic 
field moves along with it. As dictated by Faraday’s law of induction, that changing 
magnetic field will induce a current in any nearby coil. That being known, every MRI 
scanner is fitted with a coil that surrounds the object being scanned. Once current runs 
through a coil, a voltage is produced, and a device called an analog-to-digital converter 
(ADC) can be used to measure that voltage. The actual signal detected in the laboratory 
during an MRI experiment comes from electromotive force (emf), i.e. a voltage, induced 
by the flux changes due to the precession of the magnetization vectors (13). The coil used 
in MRI scan is called a receive coil because its function is to “receive” the NMR signal of 
the object being scanned.  
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Because of the relationship between the magnetization vector and NMR signal, instead of 
explaining how the rf pulse is used to manipulate the movement of individual spins in 
order to maximize the NMR signal, the focus will be on explaining how the rf pulse is 
used to manipulate a group of spins represented by the magnetization vector. To do just 
that, a 3D Cartesian coordinate system will be used to examine the magnetization vector. 
To begin, it is useful to separate the magnetization vector into its component parts: 
 
	 	 	 	 	 ̂ (14) 
 
Alternatively, the magnetization vector can be represented as the sum of only two 
vectors: 
 
	 	 	  (15) 
 
where the transverse vector ( ⟘ or ) lies in the x-y plane, and the longitudinal vector 
( ǀǀ or ) is parallel to the z-axis: 
 
	 ⟘ 	 	  (16)  
 
	 ǀǀ 	 	 ̂ (17) 
 
The transverse vector ( ⟘ or ) is perpendicular to , and the longitudinal vector ( ǀǀ 
or ) is parallel to .  
 
At the start of an MRI experiment, an object containing hydrogen nuclei, i.e. protons, is 
placed in the static external magnetic field of the MRI scanner ( ).  lines up with the 
magnetic field and begins to precess clockwise around the positive z-axis at the resonance 
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frequency. While in the static external magnetic field, the magnetization vector is said to 
be in equilibrium because the precession remains unchanged as long as the external 
magnetic field remains unchanged. For a proton, the magnetization at the start of an MRI 








Equation (18) indicates that the equilibrium magnetization of proton is directly 
proportional to the spin density and the external magnetic field. In terms of the 
component vectors,  rotates clockwise in the x-y plane at the resonance frequency, 
while  stays motionless and coincident with the z-axis. It turns out that the oscillations 
of the transverse magnetization vector induce a much greater emf in the receive coil than 
any contribution to the signal due to the longitudinal magnetization vector. In fact, the 
transverse magnetization’s contribution to the signal is so much greater than the 
longitudinal magnetization’s contribution that the contribution of the longitudinal 
component to the signal will be ignored in the remaining discussion. 
 
To further simplify things, suppose the x-axis and y-axis are also rotating clockwise at the 
resonance frequency around the positive z-axis. While in a rotating reference frame,  
does not precess. In terms of the component vectors,  is motionless and coincident 
with the y-axis, and  is motionless and coincident with the z-axis. For the sake of 
simplicity, even though thermal energy prevents  from perfectly lining with , in the 
remaining discussion  will be assumed to equal zero at equilibrium, which means that 
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period of time. Of note, an rf pulse is not a burst of radio waves (16, 17). When hydrogen 
nuclei (in a sample) are located in a static magnetic field (in an MRI scanner), the 
oscillation frequency of the oscillating magnetic field (also in the MRI scanner) is 
matched to the precessional frequency of the spins of those atomic nuclei (13). As you 
will recall from Equation (11), spins subject to a magnetic field will naturally precess at 
what is referred to as the resonance frequency or the Larmor frequency. To match the 
precessional frequency of a group of spins, the frequency of the oscillating magnetic field 
in the MRI scanner must be set such that it equals the resonance frequency of those spins. 
The oscillating magnetic field, or the rf pulse, applies torque to the magnetization vector. 
The main purpose of the rf pulse now becomes clear: it is used to rotate the magnetization 
vector. A magnetization vector in equilibrium and pointing in the direction of the positive 
z-axis is tipped 90° by the rf pulse, which explains why an rf pulse is also commonly 
called a 90° or π pulse. Once it is rotated 90°,  lies entirely in the x-y plane which 
means that the longitudinal component of magnetization is now zero while the transverse 
component is no longer zero (Figure 3b).  
 
In an MRI experiment, the moment in time when the rf pulse tips the magnetization 
vector and scanning begins is referred to as t = 0. Since the static external magnetic field 
is always on, immediately after the rf pulse is turned off, the magnetization vector moves 
back into its equilibrium position. As the magnetization vector returns to equilibrium, in 
the laboratory reference frame, i.e. not the rotating reference frame, if one were to look 
down from about the positive z-axis, the transverse magnetization vector would appear to 
spiral clockwise around the z-axis toward the origin. In contrast, in the laboratory 
reference frame, the longitudinal magnetization vector would not move from its position 
along the z-axis, but it would appear to grow in length from zero to its original 
equilibrium magnitude.  
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Following an rf pulse, while the magnetization vector is returning to its equilibrium 
position, the signal is being received and stored by the MRI scanner. In practice, the 
signals due to the components of the transverse magnetization (  and ) are received 
separately, each by a different coil. Due to the clockwise movement of the transverse 
magnetization as the magnetization vector precesses back to its equilibrium position, the 
magnitudes of the  and  laboratory signals graphed versus time each look like an 
oscillating wave. Mathematically, each oscillating wave is composed of simple sine and 
cosine waves. Although no further details will be given, it is useful to note that because 
the transverse magnetization vector is rotating in the x-y plane, the signal can be written 
as a sum of complex waves.  
 
Given a homogenous sample, homogenous static and rf fields, and no relaxation effects, 
the amplitude of the signal would be given by the following equation: 
 
| | 	 ⟘  (19) 
   
where  is the volume of the sample.  must be small enough to satisfy the given 
conditions to a good approximation. In this equation, a new magnetic field is introduced. 
As governed by Ampere’s law, when the precession of a magnetization vector induces a 
voltage in the receive coil, the resulting current flowing in the coil induces another 
magnetic field. ⟘ is the magnitude of the transverse component of the induced magnetic 
field per unit current. Equation (19) confirms that the signal strength is dependent on the 
magnetization vector, including its resonance frequency, its initial magnitude, and its 
emf-inducing precession. Under the same conditions as before, Equation (19) can be 











Thus, the signal is also directly proportional to the spin density ( ) and the square of the 
static external magnetic field ( ) (or equivalently the square of the resonance frequency 
( ). The signal is also indirectly proportional to the temperature of the sample. 
 
1.2.2.6 Magnetic Field Gradients and Creation of an MRI Image 
 
Within a uniform and static magnetic field, all identical nuclei have the same resonance 
frequency, and distinct nuclei have different resonance frequencies. For example, at the 
magnetic field strength of 3 T, the resonance frequency of all hydrogen nuclei are the 
same, but it is different from the resonance frequencies of the sodium (23Na) and 
phosphorous (31P) nuclei (13). If the strength of the magnetic field changes, so does the 
resonance frequency of each nucleus. For example, the resonance frequency of the 
hydrogen nucleus is ~128 MHz at 3 T, but it is ~400 MHz at 9.4 T. Significantly, even 
when the strength of the magnetic field changes; the hydrogen nucleus, the sodium 
nucleus, and the phosphorous nucleus continue to have unique resonance frequencies. 
 
So far it has been established that if a group of nuclei, say for example the hydrogen 
nuclei, was placed in a uniform magnetic field and if the frequency of an rf pulse was 
matched to the protons’ resonance frequency, the nuclei would give off an NMR signal 
detectable with an MRI scanner. The frequency of the rf pulse used during an MRI scan 
needs to be adjusted depending on the nuclei being analyzed and the strength of the 
external magnetic field of the MRI scanner. For example, in a 3 T scanner, the rf pulse 
would have to be set to 128 MHz in order to image the hydrogen nuclei. Importantly, 
every nucleus with the same resonance frequency, which in this example would be all the 
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hydrogen protons, would contribute to the laboratory signal. In other words, at any given 
time, the laboratory signal is the sum of all the individual NMR signals produced by each 
magnetization vector precessing in the object being imaged. Furthermore, the laboratory 
signal itself would have a frequency that was (approximately) the same as the resonance 
frequency of the hydrogen protons. Since the specific signal of the hydrogen nuclei is 
known and different from the signal of other nuclei, the collected laboratory signal would 
indicate that hydrogen was present in the group of nuclei that was scanned.  
 
Significantly, with only the static external magnetic field and the rf pulse, the laboratory 
signal cannot be used to determine the location of the nuclei within the magnetic field; 
and without knowing spatial information, it is impossible to create an image. MRI and 
NMR spectroscopy are both based on the principles of nuclear magnetic resonance 
(NMR). Although NMR spectroscopy can be used to obtain useful information about the 
chemical and physical properties of atoms and molecules, it was not until methods were 
developed to spatially localize the atoms and molecules that the first MRI images could 
be created. To obtain spatial information in the x-, y-, and z-directions, additional 
magnetic fields are needed. 
 
For starters, picture an object divided into slices, similar to a sliced loaf of bread. When 
scanning an object, an MRI scanner images one slice at a time. To select one slice, the rf 
pulse is used to systematically tip all the magnetization vectors in a slice, one slice at a 
time. As you will recall, any magnetization vector that is not tipped 90° will not produce 
an NMR signal and thus will not contribute any information to the laboratory signal. 
Slice selection occurs by turning on a third magnetic field at the same time that the rf 
pulse is on. This third magnetic field is called the slice selection gradient. The slice 
selection gradient is a one-dimensional (1D), linear magnetic field gradient, which means 
that the strength of its magnetic field increases linearly with respect to its position in 
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space. For example, the magnetic field strength of a 1D linear magnetic field gradient in 
the x-direction (Gx) increases linearly along the x-direction. Considering Equation (11), 
by linearly varying the strength of the magnetic field in space, the resonance frequencies 
of the magnetization vectors also linearly vary over that space. This occurs because each 
magnetization vector experiences a different magnetic field strength and precesses at the 
resonance frequency corresponding to the magnetic field it is experiencing. The 
frequency of the rf pulse determines which magnetization vectors are flipped 90°. Any 
magnetization vectors whose resonance frequencies do not match the frequency of the rf 
pulse will not be flipped and thus will not contribute any NMR signal to the laboratory 
signal. In the remaining discussion, assume Gz is the slice selection gradient; in which 
case, the slice that is selected is parallel to the x-y plane.  
 
After the rf pulse and slice selection gradient are turned off and a slice has been selected, 
the signal from the precessing protons needs to be collected in such a way that spatial 
information of the slice can be ascertained from the NMR signals. Two-dimensional (2D) 
information is obtained by employing two other 1D linear magnetic field gradients. If Gz 
is the slice selection gradient, then the other two gradients are Gx and Gy. The first of 
these two magnetic field gradients is called the phase encoding gradient. As mentioned 
earlier, the tip of the magnetization vector travels in a circular path. Looking down from 
above the z-axis, the transverse magnetization vector moves just like the hand of a clock. 
The vector rotates at the resonance frequency, and the angle formed by the vector and 
some reference axis such as the y-axis is called the phase angle. Stated another way, the 
movement of the magnetization vector is mathematically represented as an oscillating 
wave and thus has both a frequency and a phase. Immediately before the phase encoding 
gradient is turned on, all of the magnetization vectors in the slice are precessing at the 
same resonance frequency and with the same phase. The phase encoding gradient is then 
turned on. Assuming that the phase encoding gradient is Gy, the resonance frequencies 
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vary linearly in the y-direction. In other words, the magnetization vectors are precessing 
at increasing speeds along the y-direction. When the phase encoding gradient is turned off 
shortly after it is turned on, the magnetization vectors all return to spinning at the same 
resonance frequency; however, their phases are no longer the same. Due to the phase 
encoding gradient, the phases of the magnetization vectors vary in space. Once the phase 
encoding gradient is turned off, the second of the two linear magnetic field gradients used 
to obtain spatial information from the 2D slice is turned on. It is called the frequency 
encoding gradient. Recall that the resonance frequencies of the magnetization vectors 
increase linearly in a single direction in space when a 1D linear magnetic gradient is 
turned on. Because the magnetization vectors were already out of phase before it was 
turned on, the result of applying the frequency encoding gradient is that each 
magnetization vector in the 2D slice now precesses with a unique combination of 
frequency and phase. Since each unique combination of frequency and phase corresponds 
to a particular location within a slice, spatial information is said to be encoded in the 
frequency and phase of the laboratory signal (18). Fortunately, a mathematical tool called 
the inverse Fourier transform can decode the spatial information. Recall that the 
laboratory signal (an oscillating wave) is the mathematical sum of the NMR signals (also 
an oscillating wave) emitted by all the precessing protons in the field. To obtain spatial 
information regarding the location of all the protons in the 2D slice, the laboratory signal 
must be decomposed into its simple, component waves. The inverse Fourier transform is 
used to deconstruct the data obtained from the laboratory signal into the spatial 
information necessary to create an image. 
 
When the frequency encoding gradient is on, the signal is “sampled” and the raw data is 
stored by the MRI scanner. This completes one cycle of an rf pulse sequence. The rf 
pulse sequence is the sequence in which all the magnetic fields are turned on and off and 
the signal is sampled by the ADC. Though there are more complicated rf pulse 
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sequences, the rf pulse sequence that was described in this text began with the rf pulse 
and the slice selection gradient, was followed by the phase encoding gradient, and ended 
with the frequency encoding gradient and the ADC. 
 
Because the magnitude of the signal begins to decay over time just as soon as the rf pulse 
is turned off, the signal can only be sampled for a given period of time. Furthermore, for 
mathematical reasons, more data is required to create an image than the amount of data 
that can be collected from one rf pulse sequence. Thus, the rf pulse sequence must be 
repeated many times, usually 128 or 256 times, in order to collect enough raw data to 
produce an image of the slice. Each repetition time the sequence in which the magnetic 
fields are turned on is the same, but the magnitude of the phase encoding gradient is 
systematically increased in a stepwise fashion.  
 
1.2.2.7 MRI Hardware and Creation of an MRI Image 
 
An MRI scanner consists mainly of a large magnet to generate a strong and static 
magnetic field, radio frequency (rf) coils to transmit and/or receive magnetic fields, 
gradient coils to produce variations in the static magnetic field, and a computer to 
reconstruct the NMR signals into an image (19). Once an object is placed in the bore of 
the MRI scanner, it lies in the static magnetic field created by the large magnet. The 
hydrogen nuclei in the object align with that magnetic field, thus becoming temporarily 
magnetized. The transmit coil generates an rf pulse through the object. After the rf pulse 
is turned off, the gradient coils create time-varying magnetic field gradients in space in 
order to manipulate the precession of the hydrogen nuclei. The receive coil collects the 
signal produced by the precessing hydrogen nuclei. The computer takes the laboratory 
signal and separates it into its component parts. Thus, the computer is able to calculate 
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the number of hydrogen nuclei present at each location within the object. Finally, the 
computer forms a black and white image of the object, where the intensity of a particular 
location on the image is proportional to the number of hydrogen nuclei located in the 
corresponding location in the actual 3D object. 
 
As just described, once the ADC has finished sampling the laboratory signal, it generates 
2D images of the 3D object. To understand how a 2D MRI image relates to the 3D 
object, imagine that a very thin cross-section of the object is taken. In the field of MRI, 
the cross-sections of the object being imaged are called slices. The cross-section has a 
thickness, so like the object, it too is three-dimensional. Using a grid, the cross-section is 
then further divided into very small, equally-sized volumes called voxels. Each voxel has 
the same thickness as that of the cross-section. Using a grid, the image is divided into 
very small, equally-sized areas called pixels. Pixels are two-dimensional, so they do not 
have a thickness. By overlaying the two grids, voxels line up with pixels, such that the 
location of a small volume in the object corresponds to a particular location on the image. 
To create a black and white image, the magnitude of the signal emitted from one voxel is 
proportional to the intensity of its corresponding pixel on the image.  
 
Often, MRI images of animals or humans are of slices parallel to the transverse, sagittal, 
or coronal planes of their bodies. Even so, once an object is placed in the scanner to be 
imaged, MRI can produce images of slices spatially oriented in any direction. This ability 
is just one of the advantages of using MRI.  
 34
CHAPTER 2  
 
SELECTION OF A POTENTIAL MRI REPORTER GENE AND 
CREATION OF STABLE CLONES COMPOSED OF CELLS 
EXPRESSING THAT GENE 
 
In the beginning, we did a literature search to identify a gene that could potentially enable 
cells expressing that gene to produce greater image contrast. We focused our attentions 
on magnetotactic bacteria, since these bacteria are able to produce intracellular organelles 
containing iron oxide crystals. Iron affects the magnetization of neighboring atoms 
thereby creating a change in the NMR signal that can be visualized with MRI. Iron is a 
known negative contrast agent. When a negative contrast agent is scanned, it appears 
dark, as opposed to white or bright, on an MRI image. Cells carrying negative contrast 
agents appear darker on an MRI image as compared to cells that do not contain the 
negative contrast agent.  
 
Selection of a gene and production of cell clones was of upmost importance because 
without labeled cells, the experiments described in Chapter 3 and Chapter 4 could not be 
attempted, much less completed. From amongst genes found in magnetotactic bacteria, 
two genes, mms6 and magA, were selected for further study. These two genes were 
selected because we hypothesized that they would encode proteins that would enable 
cells expressing one or both of the genes to produce negative contrast by increasing 
intracellular iron stores. Once we selected a potential MRI reporter gene, we transfected 
cells with the gene and create stable clones. Stable clones allow for the long term imaging 
of cells. Before continuing, we confirmed that mms6 and magA were expressed and that 
the Mms6 and MagA proteins were produced in the transfected cells. Because several 
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clones expressed the genes, a systemic selection process was used to isolate the clone that 
was best able to take up iron and produce changes in MRI contrast. This selection process 
included imaging the positive clones in vitro with MRI. Imaging the positive clones also 
served to test the hypothesis that mms6-positive and magA-positive clones generate MRI 





The genes mms6 and magA are both native to magnetotactic bacteria; however, we 
wanted to study an MRI reporter gene in mammalian cells. Molecular cloning is the 
laboratory technique used to transfer a gene into cells where that gene is not normally 
expressed. Once the gene has been transfected into the cells, the cells are said to be 
positive clones or positive cells, while the original host cells, which of course do not 
express the gene, are referred to as negative cells or wild-type cells. Our first aim was to 
select a positive clone that was able to produce image contrast. On a T2-weighted MRI 
image, image contrast is based on differences in transverse relaxation times. A more 
detailed discussion on molecular cloning, reporter genes, magnetotactic bacteria, and 
relaxation times can be found immediately below. 
 
2.1.1 Molecular Cloning 
 
Based on the principles of molecular biology, molecular cloning is a method used to 
engineer recombinant deoxyribonucleic acid (DNA), to insert the recombinant DNA into 
a host organism, and to direct its exact replication in that host organism (20). 
Recombinant DNA is DNA that has been created in the laboratory, either to recreate 
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DNA molecules that are found naturally in the wild or to piece together new DNA 
molecules that are not found in nature, out of synthetic DNA pieces or out of a 
combination of DNA molecules naturally found in more than one organism. For example, 
a piece of DNA that is naturally found in a bacterium may be cloned into a mammalian or 
plant cell. The host organism used for molecular cloning is also a type of cell, such as 
mammalian or bacterial cells. Molecular cloning is possible because cells belonging to 
different organisms contain DNA with the same chemical structure. Because of the way 
in which it is engineered, the recombinant DNA molecule, once inside the host cell, is 
replicated and the progeny of the host organism receives a copy of the recombinant DNA 
molecule. In this manner, a large population of cells all containing the recombinant DNA 
can be obtained. Not only is the DNA molecule replicated by the host cell, it is also 
expressed, in other words, it is transcribed into messenger RNA (ribonucleic acid) and 
translated into a protein. The resulting protein is called a recombinant protein. 
 
In some cases, the sole purpose of molecular cloning is to multiply the number of 
recombinants in order to multiply the number or recombinant DNA molecules. In this 
case, the host organism used is typically a bacterium that can multiply quickly. For 
example, E. coli (Escherichia coli), a common bacterium used for molecular cloning, has 
a doubling time of approximately 16 minutes (min) (21). Once the large batch of cells 
expressing the recombinant DNA, also known as recombinants, is made, the foreign 
DNA may be expressed and its protein product may be isolated for study or for use. As 
an example, insulin and growth factors can be manufactured in this manner (22). Instead 
of isolating the protein, the recombinant DNA can be extracted from the host organism; 
and the DNA can be, for instance, commercially sold or can be used for further biological 
experiments. In the latter case, molecular cloning is again employed but not for the 
purpose of amplifying the DNA. Instead, one possibility is that the recombinant DNA is 
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cloned into a cell because, when that piece of DNA is expressed in the cell, the DNA 
molecule will confer a new trait to its host cell.  
 
Because proteins perform numerous and diverse biological functions, the host organism 
expressing foreign DNA can, depending on the particular recombinant DNA molecule it 
expresses, perform one of many novel functions. As the first of three examples, E. coli 
expressing the inv gene, which is naturally found in a bacterium called Yersinia 
pseudotuberculosis but not in E. coli, induces the invasion of mammalian cell lines 
expressing β1-integrin, a transmembrane protein located on the cell surfaces of several 
types of cells (23). The ability to invade mammalian cells could then be further 
engineered to allow the recombinants to selectively invade and thus kill cancer cells. To 
prevent pests from damaging crops, plants such as tobacco and tomato have been 
engineered to make a biological pesticide. The plants gain the ability to make their own 
insecticide by expressing genes normally found in the bacterium Bacillus thuringiensis 
(24). The green fluorescent protein (GFP) from the jellyfish Aequorea Victoria is used as 
a biomarker in a diverse set of cells and organisms. As a reporter gene, GFP has been 
used to observe physiological processes, localize subcellular proteins, and monitor gene 
expression (25). 
 
The trait that is conferred to the recombinant depends not only on what the function of 
the protein was in its native organism, but also on the endogenous environment of the 
host organism (26). For instance, the recombinant protein may require other proteins to 
function correctly, but those other proteins may not be present in the host organism as 
they were in its native organism. Unlike in its native cell, after it is expressed, a 
recombinant protein may not function correctly in the host cell because it is not taken to 
its correct location. As another example, the protein may not function as it did in its 
native cell because the host organism recognizes the recombinant DNA as foreign and 
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may take steps to prevent its expression. In the case of synthetic DNA, which is designed 
in a laboratory and not naturally expressed in any organism, the DNA may not function 
as expected within the host organism because the biological system in which the 
synthetic DNA molecule is designed to function is complex and not always completely 
understood (27). In other words, the synthetic DNA molecule may function in theory but 
not necessarily in practice. 
 
2.1.2 Reporter Genes 
 
A reporter gene makes cells expressing the reporter gene visible either with the naked eye 
or with the use of an imaging modality. A reporter gene functions by expressing a protein 
or functional RNA that ends up producing a phenotype that makes the cells visible. In the 
case of the green fluorescent protein, GFP produces green fluorescence when it is 
activated with ultraviolet light. In the case of MRI, whatever the phenotype gained by 
cells expressing an MRI reporter gene, it must result in the enhancement of the cells’ 
MRI image contrast.  
 
With any MRI reporter gene, it is possible to genetically engineer the reporter gene and 
its regulatory units such that it is possible to produce tightly-controlled contrast. For 
instance, a reporter gene construct may be designed such that the reporter gene is 
upregulated or downregulated only in certain tissues or only in response to a specific 
biological events, such as proteomic or metabolic changes (2). It is also possible to design 
the reporter gene such that it can be turned on and off at will by placing it under the 
control of a gene regulatory protein (28). The expression of the gene would then be 
controlled by restricting its contact with that protein which, depending on the protein, 
either promotes or prevents the expression of the gene. For strict control, the regulatory 
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protein should not be present in the cells expressing the reporter gene, but it should be 
easily delivered to the cells as needed. In contrast, the reporter gene may instead be 
constitutively expressed so that there is no need for a regulatory protein. An MRI reporter 
gene which is constitutively active encodes its protein constantly, so cells expressing a 
constitutively active reporter gene generate MRI contrast every time they are imaged with 
MRI. 
 
2.1.3 Magnetotactic Bacteria 
 
As the name indicates, magnetotactic bacteria are capable of magnetotaxis, which is the 
ability to detect, orient, and navigate along the Earth’s geomagnetic field (29, 30). They 
are able to migrate along magnetic field lines because the bacteria synthesize and 
intracellularly align a number of organelles called magnetosomes that act like compass 
needles. In our search for a gene which have the potential to enable cells to enhance MRI 
contrast, we directed our attention to genes unique to magnetotactic bacteria not simply 
because they are capable of magnetotaxis but because it was discovered that the reason 
they are capable of magnetotaxis is because their specialized organelles, or 
magnetosomes, contain magnetic, iron-bearing crystals. These nano-sized crystals are 
comprised of biominerals, either the magnetic iron oxide magnetite, Fe3O4 or, less 
commonly, the magnetic iron sulfide greigite Fe3S4 (31). To form the crystals, the 
bacteria must transport iron into the magnetosome, which is enveloped by an organic 
membrane, a protein-containing lipid bilayer called the magnetosome membrane (32). 
Specific proteins are required for the uptake and transport of iron from the extracellular 
space across the cell membrane and the magnetosome membrane and into the 
magnetosome. Once inside the cell, the iron goes through a process of biomineralization 
to convert it to magnetite or greigite (31). 
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magA was discovered in a study where five non-magnetic magnetotactic bacteria were 
generated by the insertion of transposon Tn5 into the genome of a strain of magnetotactic 
bacteria named Magnetospirillum sp. AMB-1 (33). Because the transposon caused a 
mutation in the genome that resulted in a change in phenotype, it was deduced that the 
mutated DNA fragment was required for synthesis of magnetic particles. Researchers 
sequenced that DNA fragment and ended up isolating a 1.3 kilobase (kb) gene which they 
named magA. When they compared its sequence to other bacterial DNA, they found that 
magA is homologous to cation efflux proteins and concluded that magA likely encodes an 
iron transporter involved in the synthesis of magnetic particles in the magnetotactic 
bacteria (34). Furthermore, intracellular localization of the magA protein was examined 
using a MagA–luciferase fusion protein. The results indicate that this protein is a 
membrane bound protein localized in both the cell membrane and magnetosome 
membrane (35). However, recent evidence argues that magA is neither necessary for the 
biomineralization process nor an iron transporter and suggests that it is also not a 
magnetosome membrane protein (36, 37).  
 
Unlike magA, mms6 is a 411 base pair magnetotactic bacteria-specific gene. In other 
words, it has no homology to other proteins in non-magnetic organisms (38). It was first 
discovered when researchers isolated and analyzed magnetosome membrane proteins. 
One of the proteins that was extracted was a low molecular mass protein bound tightly to 
the magnetosome membrane of the magnetotactic bacteria Magnetospirillum strain 
AMB-1 (39). This protein was named Mms6. To study its function, the same researchers 
also created a recombinant Mms6 protein in E. coli which they used in an iron-binding 
assay and found that recombinant Mms6 was able to bind iron. In a separate study, 
recombinant Mms6 was also found to bind iron and was shown to play a role in the in 
vitro formation of uniform 30 nanometer (nm)-sized, superparamagnetic magnetite 
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crystals (40). In a more recent study, mms6 was deleted from the magnetotactic bacteria 
Magnetospirillum magneticum AMB-1. Electron micrographs revealed that the mutant 
strain synthesized smaller and irregularly shaped magnetite crystals as compared to the 
wild-type strain (41). Together, these results characterize Mms6 as an iron-binding 
protein that regulates the size and shape of growing magnetite crystals.  
 
2.1.4 Transverse and Longitudinal Relaxation 
 
2.1.4.1 Longitudinal and Transverse Relaxation 
 
Recall that the magnetization vector is the sum of the dipole moment vectors in a 
homogenous isochromat. When the external, static magnetic field  points in the 
direction of the positive z-axis, the magnetization vector also points in the direction of the 
positive z-axis. It remains in equilibrium until the rf pulse flips the magnetization vector 
to the x-y plane at t = 0. Once the magnetization vector is flipped, the longitudinal 
magnetization is at its minimum value (i.e. zero), and the transverse magnetization is at 
its maximum value ( 0 ). Starting at t = 0, the longitudinal component of 
magnetization is given by: 
 
	 	 	 1 	 /  (21) 
 
where  is the magnitude of the magnetization vector at equilibrium. This equation 
corresponds to the situation where the rf pulse experiment begins at t = 0 and not at some 
other arbitrary starting point. T1 is called the spin-lattice relaxation time or the 
longitudinal relaxation time. As expected, the equation describes the regrowth of the 
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flux. The changes in magnetic flux are caused by the precession of the magnetization 
vectors. Since the signal is closely linked to the transverse magnetization, it is not 
surprising that as the transverse magnetization decays so does the laboratory signal. If the 
signal decays too quickly, the ADC will not be able to collect enough data to produce a 
good MRI image. During an MRI scan, additional magnetic fields can be added to the rf 
pulse sequence to lengthen the time it takes for the signal to decay, thus giving the ADC 
enough time to collect the data needed to form a good image. For example, in a spin echo 
sequence, several 180° pulses, also called π pulses, are applied at regular intervals to 
regrow the signal each time it decays.  
 
When the rf pulse is turned off at t = 0, the magnitude of the signal ( ) is at a maximum. 
It immediately begins to decay. When the 180° pulse is applied, the magnitude of the 
signal will regrow until it reaches a peak and begins to decay once again. Every time the 
signal decays, another 180° pulse can be applied. 180° pulses cannot be applied infinitely 
because each time the signal peaks, its magnitude is only a fraction of what it used to be 
(Figure 5a). By tracking only the magnitude of the signal when it peaks, a mathematical 
curve can be used to describe the manner in which the signal decays. As illustrated in 
Figure 5b, the signal decays exponentially ( / ). As expected, the laboratory signal 
of a multiple spin echo sequence is limited by the transverse relaxation time of the 
magnetization vector (T2). The signal of an object will decay slower if it has a long T2 
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MRI is an imaging technology that generates an image by taking advantage of the 
physical principles of nuclear magnetic resonance. When an object or subject lies in an 
MRI scanner, a strong magnet aligns all the unpaired dipole moments in the atoms of that 
object. Then, a radio frequency pulse, or a magnetic field oscillating with a radio 
frequency, is applied to the object causing the dipole moments to rotate. Once the rf pulse 
is turned off, the dipole moments of the atoms return to their original position. Because 
the dipole moments of different atoms do not return, or relax, to their original position at 
the same rate, an MRI image of the object can be created after the MRI scanner records 
the time it takes the dipole moments in the object to relax and mathematically translates 
that information into an image (42, 43). If the protons in two adjacent objects have 
different relaxation times, image contrast between the two objects can be generated by 
making the different relaxation times correspond to different signal intensities in the final 
MRI image. 
 
There are two different relaxation times that are measured and used to produce an image, 
the longitudinal (T1) and transverse relaxation (T2) times. The image contrast between 
two objects or two tissues can be increased if the difference between their T2 relaxation 
times is greater than the difference between their T1 relaxation times, or vice versa. In 
that case, T1-weighted or T2-weighted MRI can be used to emphasize one relaxation time 
over the other. In T2-weighted images, short T2 relaxation times produce hypointensities 
on the image and long T2 relaxation times produce hyperintensities. The opposite is true 
in T1-weighted images; short T1 relaxation times produce hyperintensities on the image 
and long T2 relaxation times produce hypointensities. Hyperintensities appear as bright 






2.2.1 Creation of Stable Clones 
 
After we made the decision to examine the possibility that mms6 and magA could be used 
as MRI reporter genes, the first objective was to generate stable, single cell clones. A 
single cell clone is a group of cells comprised entirely of the progeny of a single cell so 
all the cells are identical. Using the same clone for all experiments in a study is ideal 
because using different clones could potentially introduce a confounding variable into an 
experimental design. A stable single cell clone is simply a single cell clone that has been 
transfected with a gene whose expression levels remain stable, often over a period of 
months or even years. The creation of stable single cell clones, which from now on will 
be referred to simply as a clone, saves time by making it unnecessary to have to transfect 
cells often. Because the clonal cell line can be expanded, all experiments can be 
conducted with the same clone.  
 
We obtained the genetic sequences for magA and mms6 from Genbank, an online 
database, and custom-ordered the genes from a commercial vendor. Because magA and 
mms6 are native to bacterial genes, the nucleotide sequences were optimized for 
expression in mammalian cells. In other words, the nucleotide sequence was altered 
slightly from the sequence published online to ensure that the Mms6 protein being 
expressed in the mammalian cells would be identical to the one being expressed in the 
magnetotactic bacteria. Once we received the two plasmids, we used standard subcloning 
methods to transfer the genes to a vector of our choosing. Basically, we used restriction 
enzymes to excise each gene from its parent vector, i.e. the vector in which it came, and 
used a ligase to clone each gene into a vector called pBudCE4.1. With pBudCE4.1, a 4.6 
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kb vector, two genes can be simultaneously, constitutively expressed in mammalian cell 
lines and clones can be generated. We chose a constitutively active vector to regulate our 
genes because an inducible vector requires the presence of a regulatory protein to turn 
gene expression on or off. Since we wanted to express our genes in vivo, we preferred not 
to face the challenge of assuring that the regulatory protein was reaching the vector. The 
vector contains the regulatory sequences that will flank the gene once it is ligated into the 
vector. The regulatory sequences control the expression of the gene in the host cell. In 
addition, pBudCE4.1 adds an epitope tag to the C-terminal end of the recombinant 
protein. We chose to add unique tags to MagA and Mms6 because the epitope tag can be 
used for the detection and purification of the recombinant protein (44).  
 
Once each gene was in its own destination vector, we wanted to confirm that the genes 
had not been mutated during the subcloning process. The genes, now cloned into a vector 
of our choosing, were sent to an outside vendor for sequencing. We compared the 
sequences of the genes cloned into pBudCE4.1 with the optimized sequences we had 
ordered and confirmed that the two sequences were identical.  
 
Next, we needed to choose the cell lines that we would be transfecting. We wanted to test 
more than one type of adherent, mammalian cell line, so we chose rat gliosarcoma cells 
called 9L cells, human kidney epithelial cells called 293T cells, and mouse hepatoma 
cells called Hepa 1-6 cells. 9L cells were chosen because they could be used in future rat 
in vivo experiments, and the 293T cells were chosen for their high transfectability. Hepa 
1-6 cells were chosen because they could be used in future mouse in vivo experiments.  
 
To transfect our cell lines, we chose a lipid-based transfection technique called 
lipofection. Lipofection is a technique used to transfer genetic material into a cell. First, 
DNA is coupled with liposomes to form a DNA-lipid complex (45, 46). The method by 
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which the complex is then internalized and transported into the nucleus is not well 
understood, but there evidence suggests that the complex enters the cell via endocytosis 
and that the liposome then enters the nucleus either by directly fusing with the nuclear 
envelope or by depositing the DNA-lipid complex into the cytoplasmic matrix where it is 
transported to the nucleus (47). Despite the fact that not much is known about the 
pathway of this transfection method, we chose to use lipofection because it is an 
established transfection technique that is widely used, inexpensive, easy to use, and 
suitable for transient, stable, and co-transfection of mammalian cells (45). 
 
Lipofection is not 100% efficient, so after the reagent is used to transfect a group of cells, 
cells that are successfully transfected are mixed with cells that are not. Cells that are 
transfected need to be separated from cells that are not transfected. Because the gene 
construct included an antibiotic resistance gene, standard cell cloning techniques were 
used to kill negative cells, i.e. cells that do not express the gene of interest, while leaving 
alive the positive cells, i.e. cells that contain the gene of interest. Briefly, once we 
transfected the cells, the antibiotic Zeocin was added to the cell culture medium. After a 
few days, only cells expressing the Zeocin resistance gene, cells which also express 
mms6 or magA, survived. At this step in the process, adding Zeocin to the cell culture 
medium served a dual purpose: it not only killed the negative cells, it also began the 
process of selecting stably transfected cells. Transiently transfected cells lose the 
transgene and their antibiotic resistance genes over time. If Zeocin were no longer added 
to the growth medium after the death of all the cells that had not been successfully 
transfected, over time, the remaining cells would once again become a mix of positive 
and negative cells. Zeocin must always be added to the medium to kill any cells that lose 
the transgene. The antibiotic is thus used to create a stably transfected cell line.  
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During transfection, a transgene integrates into the genome randomly, and the site of 
integration can mutate native genes as wells as affect transgene expression. Even if two 
different cells were the progeny of the same transfected negative cell line, were 
transfected with the same gene, and were transfected in the same manner; the cells would 
not be identical. Stably transfected positive clones must thus be created. To do this, a 
single positive cell and its progeny needs to be separated from the other stably transfected 
cells. This occurs at the end of the antibiotic selection process. When Zeocin was added 
to the cells in order to kill the cells that were not transfected, the remaining positive cells 
were subcultured into cell culture dishes such that only a limited number of cells were 
grown on each dish. After the cells attached to the cell culture plate, a single cell had 
enough room to divide without it or its progeny ever nearing any other cells. To isolate 
positive clones, a single cell and its progeny were transferred to their own culture dish. 
The end result was the successful creation of a positive clone. To increase the probability 
that the selected clones were indeed pure, we repeated the last part of the cell cloning 
process: single cell cloning. In other words, the clonal cells were subcultured into cell 
culture dishes such that only a limited number of cells were grown on each dish. Single 
cells and their progeny were once again isolated. 
 
2.2.2 Selection of a Positive Clone for Further Study  
 
Once magA-positive and mms6-positive clones were created, we decided to screen the 
newly created clones to determine which of the clones could produce the most in vitro 
contrast. We did this for two reasons. First, not all clones necessarily produce the same 
amount of contrast, even if they are clones originating from the same host cell line and 
expressing the same gene. The difference arises because every time a cell is transfected 
with a gene, the gene integrates in random parts of the genome; and the particular 
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integration site will affect gene expression (48). Second, the clone able to produce the 
most in vitro NMR signal is probably the best candidate for in vivo imaging because the 
higher the NMR signal produced by a clone in vitro, the more likely that its signal will be 
distinguishable in vivo from the signal produced by surrounding biological tissue and thus 
the more likely the cells will be visible on an MRI image. In other words, the detection of 
the NMR signal produced by cells surrounded by animal tissue is significantly more 
difficult than the detection of that signal when those same cells are collected in a tube and 
are surrounded by air, as is the case in the in vitro imaging of the cells. Thus, given the 
low sensitivity of MRI, it was essential that we selected cells that were the strongest in 
vitro producers of contrast—the stronger the better considering the threshold for in vivo 
detection of cells is high. 
 
The goal of the selection process was to identify the positive clone whose MRI image 
contrast increased the most compared to wild-type cells, presumably due to the 
expression of the recombinant reporter. We could have just imaged all of the clones to 
directly find the one that was able to produce the most image contrast; however, growing 
up the number of cells necessary for imaging is expensive and requires lots of materials 
and reagents. Instead, we wanted a faster and easier process to eliminate the clones with 
the least potential to produce contrast. In the magnetotactic bacteria, we believed at the 
time that magA expressed a protein that was a putative iron transporter, and mms6 
expresses an iron binding protein, so we thought there was a good chance that both 
recombinant proteins would increase intracellular iron storage. If we were right, then the 
iron stores would be visible by histological staining of whole cells growing on a cell 
culture dish.  
 
When ferrocyanide comes in contact with iron, the Prussian blue dye is formed in situ. 
Under a microscope, blue deposits indicate the presence of iron. Prussian blue staining 
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requires only one plate of cells and does not take too long to complete. We thus used 
Prussian blue staining as a high throughput way to identify the clones that were able to 
take up more iron than host cells. The iron pool from which they could take iron was 
present in the culture growth media. Before being stained, that media and any iron that 
had not been taken up by the cells were removed from the plate. 
 
The selection process occurred as follows: First, all clones were stained with Prussian 
blue. The number of blue deposits was visually assessed, and each clone was given a 
score of 1 to 4. A score of 1 was assigned to any clone that had approximately the same 
number of blue deposits as the host cells. In other words, these cells contained 
approximately the same amount of iron as the negative cells. The greater the number of 
blue deposits observed under the microscope, the higher the score the clone was given. 
Clones that received higher scores were then analyzed for transgene expression. The 
remaining clones were eventually discarded.  
 
The clones that were created should have been, in theory, stable single cell cells; 
however, we wanted to confirm that the clones not only expressed the transgenes but also 
expressed the recombinant proteins. After a few days of growth and division, we took 
each clone and used RT-PCR (reverse transcription-polymerase chain reaction) and 
Western blot analysis to confirm that the transgenes were being transcribed and 
translated, respectively. 
 
RT-PCR is used to detect the presence of the recombinant messenger RNA (mRNA) in a 
process that involves the use of two custom-made primers. When the total mRNA of a 
genome is mixed with the primers, the primers selectively anneal to the mRNA of 
interest, one at each end of the nucleotide sequence. Through the process of reverse 
transcription, cDNA is made using the piece of mRNA flanked by the primers as a 
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template. If the mRNA of interest is not located in the genome being analyzed with RT-
PCR, then the two primers would have nowhere to bind, and the cDNA would not be 
made. RT-PCR was used to confirm that the transgenes were transcribed in the positive 
clones. 
 
A Western blot is used to detect the presence of a protein of interest in a process that 
involves antibodies. The total protein of a clonal cell line is separated by size with gel 
electrophoresis. The total protein is transferred to a membrane and stained with 
antibodies that will selectively bind the protein of interest. The antibody is linked to a 
reporter enzyme with a chemiluminescent substrate. When the enzyme acts on its 
substrate, the luminescence can be detected with spectrophotometric methods. If the 
antibody is not detected, then the protein of interest was not expressed in the clonal cell 
line. A Western blot was used to confirm that the recombinant protein was present in the 
positive clones. 
 
As the final step of the selection process, the clones were imaged with MRI. To measure 
the MRI contrast, the T2 values of the cell pellets were measured at 3 T. We quickly 
discovered that without supplementing the cell culture medium with iron, the positive 
clones did not produce a significant change in contrast. We chose the experimental 
conditions of the imaging study based on magA research that had previously been 
completed in our laboratory (49). Basically, cells were cultured in a culture dish with 
medium supplemented with iron. Specifically, we cultured 9L and 9L4S cells for three 
days with cell culture media containing 200 micromolar (µM) of ferric citrate because a 
previous study found that when their positive clones are grown in medium with this 
concentration of iron and for these number of days, their positive clones produce 
maximum in vitro contrast (49). Then, the cells were transferred to a 1.5 milliliter (ml) 
tube and allowed to settle by gravity. Instead of letting the cells settle by gravity, the cells 
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could have been suspended in an agarose gel or could have been centrifuged. We found 
that the relaxation times of the cell samples differed depending on which of these three 






2.3.1 Cell Culturing 
 
Three types of adherent, mammalian cells were transfected: 9L cells (generously donated 
by Dr. Hyunsuk Shim (Emory University, Atlanta, GA, USA)), Hepa 1-6 cells (ATCC, 
Rockville, MD, USA), and 293T cells (ATCC). Cells were grown in 100 millimeter 
(mm) cell culture plates containing 10 ml of cell culture medium. The cell culture 
medium was 90% volume to volume (v/v) DMEM (Dulbecco's Modified Eagle's 
Medium) and 10% (v/v) of non-heat inactivated FBS (fetal bovine serum), supplemented 
with 100 units (U)/ml of penicillin and 100 U/ml of streptomycin. According to the 
manufacturer, the DMEM (ATCC) contained 0.00010 milligrams (mg)/ml of ferric 
nitrate (Fe(NO3)3·9H2O). Cells were grown at 37 degrees Celsius (°C) in an incubator 
containing 5% carbon dioxide (CO2) and 95% air. The cell culture media used to culture 
positive clones was supplemented with 0.5 mg of Zeocin per ml. 
 
2.3.2 Molecular Cloning  
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We selected both mms6 and magA for our molecular MRI studies. The genetic sequences 
of the genes mms6 and magA, both native to the magnetotactic bacterial, were obtained 
from GenBank and NCBI (National Center for Biotechnology Information) (50). Because 
the genetic sequences of mms6 and magA vary slightly between species, gene sequences 
from three magnetotactic bacterial species were ordered. The mms6 genes from 
Magnetospirillum magneticum strain AMB-1 and Magnetospirillum gryphiswaldense 
strain MSR-1 were ordered. The accession number for the former is NCBI Reference 
Sequence NC_007626.1 and for the latter is GenBank AM085146.1. The magA genes 
from Magnetospirillum magneticum strain AMB-1 and Magnetospirillum 
magnetotacticum strain MS-1 were ordered. These genes were synthesized in the form of 
complementary DNA (cDNA) from several commercial vendors, including Addgene 
(Cambridge, MA, USA), Bio Basic (Markham, ON, Canada), and GenScript (Piscataway, 
NJ, USA). Following the manufacturer’s instructions that accompanied the vector, 
standard subcloning techniques were used to clone each gene into its own pBudCE4.1 
vector (Invitrogen, Carlsbad, CA, USA), a constitutively active expression vector that 
comes with a Zeocin-resistant gene, an EF-1α promoter, and a polyhistidine-tag (V5-
His). Of note, the gene was ligated into the cloning site after the vector was linearized 
with the restriction enzymes Kpn I and Bgl II.  
 
2.3.3 Creation of Stable Clones 
 
Following the manufacturer’s instructions, Lipofectamine™ 2000 (Invitrogen) was used 
to transfect 9L cells, Hepa 1-6 cells, and 293T cells with mms6-positive vectors. We did 
the same with magA-positive vectors. Cells were not transfected with more than one 
gene. For transfection, cells were grown on a 100 mm plate and transfected with 24 
micrograms (µg) of plasmid and 60 microliters (µl) of Lipofectamine. 
 55
 
After transfection, stable clones were created following the manufacturer’s instructions 
that came with the pBudCE4.1 vector. In summary, transfected cells were seeded in 
seven 100 mm cell culture plates, 5.5 105 cells per plate, with fresh cell culture medium 
containing no Zeocin. The following day, the cell culture media of the seven plates was 
replaced with media supplemented with varying concentrations of Zeocin to determine 
the minimum amount of Zeocin necessary to kill the untransfected host cells. The seven 
concentrations of Zeocin were 0, 50, 125, 250, 500, 750, and 1,000 µg of Zeocin per ml 
of media. The selective medium was replaced every 3-4 days. By observing the cells 
under the microscope, the minimum concentration of Zeocin necessary to kill the 
untransfected host cells between seven and ten days was determined to be 500-750 
µg/ml. These cells were discarded because they could not be used to select single cell 
stable clones. Instead, the process of single cell cloning began. Another batch of host 
cells was transfected with Lipofectamine following the manufacturer’s instructions. 48 
hours (hr) after transfection, 5.5 105 cells were seeded in a 100 mm plate with cell 
culture media containing no Zeocin. A few hours later, the cells had attached; and the cell 
culture media was supplemented with 750 µg of Zeocin per ml of media. Over the next 
few weeks, the media and the Zeocin were replenished every 3-4 days. During that time, 
the cells were observed under a microscope. Any single cells that expanded into colonies 
were isolated by washing the cells with phosphate buffered saline (PBS) and adding 
trypsin EDTA (Ethylenediaminetetraacetic acid) directly on the colony. Trypsin detaches 
cells from the plate. The colony was carefully transferred to a cell culture plate 
containing cell culture medium supplemented with 500 µg of Zeocin per ml of media. 
The cells in the colony, i.e. stable single cell clones, were given time to grow to 
confluency before being subject to another round of single cell cloning. The end result 
was the creation of magA-positive and mms6-positive stable clones.  
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2.3.4 Prussian Blue Staining  
 
The clonal cells and host cells were each incubated with culture media containing 0 and 
200 µM of iron (ferric citrate (Sigma-Aldrich, St. Louis, MO, USA)) at 37 °C for a 
period of three day. The cells were then washed with PBS and fixed with 4% 
paraformaldehyde. Iron staining assays were performed following the manufacturer’s 
instructions accompanying the Prussian Blue Stain Kit (English Scientific, Clifton, NJ, 
USA). The assay entails treating cells with a 1:1 mixture of 5% potassium ferrocyanide 
and 5% hydrochloric acid (HCl) acid for 30 min and then staining them with Nuclear Fast 
Red for 10-15 s. After staining the cells, the cells were viewed under an Olympus IX71 
epifluorescence microscope equipped with a digital color CCD camera. Clones with the 
greatest amount of blue deposits, an indication of the presence of iron, were then subject 
to RT-PCR analysis and Western blot analysis.  
 
2.3.5 RT-PCR Analysis 
 
Following the manufacturer’s instructions, TRIzol® Reagent (Invitrogen) was used to 
isolate the total mRNA from the positive clones and the host cells. Also following the 
manufacturer’s instructions, SuperScriptTM III First-Strand Synthesis System for RT-PCR 
(Invitrogen) was used to synthesize the cDNA of the recombinant mRNA. The sequences 
of the two primers used in the RT-PCR reaction to detect the expression of mms6 were 5′-
GCGTGCCGGTTGGTACGAAA-3′ and 5′-AGTTCCACCTCTTCGTCGGACTGGG-3′ 
(GenBank accession number AB096081.1), and the primers for β-actin were 5′-
GACAGGATGCAGAAGGAGAT-3′ and 5′-TGCTTGCTGATCCACATCTG-3′ 
(GenBank accession number X00351 and NM_031144.3). 35 cycles of PCR were 
performed: denatured at 94 °C for 30 s, annealed at 60 °C for 30 s, and extended at 72 °C 
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for 30 s. The PCR products were separated by electrophoresis, stained with ethidium 
blue, and viewed with a transilluminator. A 1.5% agarose gel was used to resolve the 
PCR products by electrophoresis. 
 
2.3.6 Western Blot Analysis  
 
M-PER Mammalian Protein Extraction Reagent (Thermo Fisher Scientific, Rockford, IL, 
USA) was used for the extraction of total protein from 1 107 cells. The protein was then 
quantified using the Pierce BCA® Protein Assay Kit (Thermo Fisher Scientific). The 
protein samples (30 µg/lane) were resolved with gel electrophoresis using a 12% SDS-
PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis) gel. The proteins 
were then electrophoretically transferred to a nitrocellulose membrane (Thermo Fisher 
Scientific). After blotting, the membrane was blocked with 5% (v/v) fat-free milk in 0.1% 
(v/v) Tween 20 in PBS (PBST). To detect the protein, membranes were incubated 
overnight at 4 °C with either anti-V5 mouse monoclonal antibody (1:1,000; Invitrogen, 
Carlsbad, CA, USA) or anti-β-actin mouse monoclonal antibody (1:5,000; Sigma, St. 
Louis, MO, USA). Recombinant Mms6 had a V5-His tag, and β-actin was used as a 
loading control. Membranes were washed three times with PBST before being incubated 
with the secondary antibody, a horseradish peroxidase (HRP)-conjugated antibody 
(1:10,000; Sigma-Aldrich). 
 
2.3.7 In Vitro Imaging 
 
Each stable clone was subcultured into 24 100 mm plates. The host cells served as the 
control cells and were also subcultured into 24 plates. The cells grew under one of two 
conditions. The cell culture media in half of the plates (12 of them) was not supplemented 
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with iron, and the cell culture media in the other half of the plates was supplemented with 
enough ferric citrate to make the concentration of iron in the media 200 µM. The iron 
used to supplement the media was ferric citrate. Once the complete growth media was 
added to the plates, the cells were left to grow undisturbed for three days in the incubator. 
After three days, the cells had grown to ~90-95% confluency. The culture media was 
removed from the plates, and the cells were washed with PBS. To detach the cells, 1 ml 
of trypsin EDTA was added to each plate. After five min, 3 ml of cell culture medium 
was added to each plate. For each experimental condition, the 12 plates were divided into 
four groups of three plates. The cells from each group were combined and put into 
separate 10 ml tubes. The cell solution was centrifuged for 5 min at 1,000 rotations per 
minute (rpm). The supernatant was removed, and the cell pellets were resuspended in 1 
ml of PBS and placed into separate 1.5 ml tubes. The cells were then given time to settle 
by gravity for two to three hr at 4 °C. The cell pellet was then imaged with MRI. Since 
each cell pellet is considered one sample, in the end, there were four samples per 
experimental condition. 
 
As a preliminary study, some cells were imaged immediately following transfection. 
These cells were only transiently transfected. Cells that were growing on a 100 mm cell 
culture plate with 15 ml of cell culture medium and that were ~90-95% confluent were 
transfected with Lipofectamine according to the manufacturer’s instructions, with one 
exception: After the vector and Lipofectamine were added to the culture medium in the 
100 mm cell culture plate, iron was also added. Enough ferric citrate was added to the 
cell culture medium to make the concentration of iron in the medium 133 or 400 µM. The 
cells were placed in the incubator for 23 or 48 hr. The cells from the plate were collected 
in a 1.5 ml tube and centrifuged at 5,000 rpm for one min at room temperature. With such 
a small number of cells in the tube, the supernatant might affect the T2 measurements, so 
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the supernatant was removed. The tubes were tapped to loosen the cell pellets and were 
taken to the scanner for imaging at 3 T. 
 
The cell pellets were imaged in a 3 T MRI scanner (Siemens Magnetom Trio TIM® 3 T 
whole body MRI scanner, Siemens Medical Solutions, Malvo, PA, USA) with a multi-
slice multi-echo (MSME) spin echo sequence. The following imaging parameters were 
used: repetition time (TR) = 2,000 ms, echo time (TE) = 10-200 ms in increments of 10 
ms, echoes = 20, and slice thickness = 1 mm. The transverse relaxation times (T2) of the 
cell pellets were calculated by fitting signal decay curves produced from the MSME 
sequence. The T2 values of all the cell samples prepared under the same experimental 
condition were averaged. The results are sometimes reported in the form of the T2 percent 
change: 
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where “T2 of cells” is the average T2 value of cells incubated with or without iron 
supplemented medium, and “cells” refers to cells of the same cell line, either positive 
clones or control cells. Image processing and analysis were performed using MATLAB 
and Excel 2010. For in vitro experiments, three measurements were made, and error bars 






From amongst the magnetotactic bacteria genes, two genes whose protein products were 
believed to be involved in the regulation of iron in the magnetotactic bacteria were 
chosen at potential MRI reporter genes. The first gene, mms6, binds iron and has a role in 
regulating the size and shape of the iron oxide crystals found within specialized 
organelles of the magnetotactic bacteria. When it was selected for this project, the second 
gene, magA, was considered a putative iron transporter. These two genes were transfected 
into three mammalian cell lines, 9L cells, Hepa 1-6 cells, and 293T cells. Because the 
nucleotide sequences of mms6 and magA in three different strains of magnetotactic 
bacteria, MSR-1, AMB-1, and MS-1 are not identical; four different genes were used for 
transfection: the MSR-1 mms6 gene, the AMB-1 mms6 gene, the MS-1 magA gene, and 
the AMB-1 magA gene. As a preliminary study, Hepa 1-6 cells were transiently 
transfected with the AMB-1 mms6-positive pBudCE4.1 vector and the MSR-1 mms6-
positive pBudCE4.1. The cells were incubated for 23 hr with 133 µM iron. As 
hypothesized, the mms6-positive cells had a smaller T2 value than the host cells grown 
under the same conditions. The T2 values of the host cells, of the cells transiently 
transfected with the AMB-1 mms6-positive pBudCE4.1 vector, and of the cells 
transiently transfected with the MSR-1 mms6-positive pBudCE4.1 vector were 144 ms, 
88 ms, and 84 ms, respectively. Interestingly, Hepa 1-6 cells grown for 23 hr without any 
iron supplement had a T2 value of 117 ms. Because iron decreases T2 values, we did not 
expect the T2 value of Hepa-1 cells grown without an iron supplement (117 ms) to be 
smaller than the T2 value of the Hepa 1-6 cells grown with an iron supplement (144 ms).  
 
293T cells were transiently transfected with the AMB-1 magA-positive pBudCE4.1 
vector and the MS-1 magA-positive pBudCE4.1 vector. The cells were incubated for 48 
hr with 400 µM iron. Based on the results of previous research (49), we expected the 
magA-positive cells to have a smaller T2 value than the host cells grown under the same 
conditions; but there was no statistical difference between the values. The T2 values of 
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the host cells, of the cells transiently transfected with the AMB-1 magA-positive 
pBudCE4.1 vector, and of the cells transiently transfected with the MS-1 magA-positive 
pBudCE4.1 vector were 211 ms, 204 ms, and 200 ms, respectively. 
 
Using molecular cloning techniques, several dozen magA and mms6-positive clones were 
created out of the different combinations of genes and host cells. Because we started 
working with magA long before we started working with mms6, magA-positive clones 
were not subject to an elimination process. Instead, newly created stable clones were 
immediately imaged at 3 T. Despite repeated attempts, no difference in T2 values was 
measured (data not shown). RT-PCR and Western blot analysis confirmed that the magA 
was expressed in the clones (data not shown), yet the clones did not produce statistically 
significant changes in T2. The imaging results of the stable clones are consistent with the 
imaging results of the transient transfection of 293T cells with magA. 
 
Because a few dozen mms6-positive clones had been created, we focused our attentions 
on 9L clones and 293T clones. This decision was made because the 9L cells could be 
used to create the animal model we eventually wanted to create and because the 293T 
cells had been successfully used to test an MRI reporter gene in a previous study (49). 
Thus, the Hepa 1-6 clones were frozen in liquid nitrogen for long term storage. 
 
Only the mms6-positive 9L and 293T clones were subject to the elimination process. 
First, 28 mms6-positive 9L clones and 11 mms6-positive 293T clones were analyzed with 
Prussian blue staining. The number of blue deposits observed in the clones was compared 
to the number of blue deposits in the host cells. The number of blue deposits was visually 
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Table 1: Systematic selection of an mms6-positive 293T clone with the greatest MRI 
contrast. After transfection with mms6, 293T single cell clones were isolated and then 
put through the following selection process: First, 293T clones were stained with 
Prussian blue. The amount of blue stain was visually evaluated and assigned a score from 
1 to 4. Clones were assigned a score of 1 if they showed the same level of staining as 
control cells (293T cells). Clones that showed the greatest level of blue staining were 
then analyzed for mms6 expression with RT-PCR and Western blot. Then, mms6-positive 
293T clones were imaged with MRI. The percent decrease in the value of T2 was used as 












1  1          
2  3  Y  N    
3  3  Y  Y  34.0% 
4  3  Y  Y    
5             
6  1          
7  3  Y  Y  25.9% 
8  2  Y  N    
9  3  Y  Y    
10  3  Y  Y  20.2% 
11  3  Y  Y  19.1% 
12  2          
13  1          
14  1          
15  1          
16  2          
17  1          
18  3  Y  Y  23.1% 
19  3  Y  Y  18.2% 
20  1  Y  N    
21  1          
22  1          
23  2          
24  2          
25  3  Y  Y  25.0% 
26  1          
27  1          
28  1          
29             




Table 2: Systematic selection of the mms6-positive 9L clone with the greatest MRI 
contrast. After transfection with mms6, 9L single cell clones were isolated and then put 
through the following selection process: First, 9L clones were stained with Prussian blue, 
an iron stain. The amount of blue stain was visually evaluated and assigned a score from 
1 to 4. Clones were assigned a score of 1 if they showed the same level of staining as 
control cells (9L cells). Clones that showed the greatest level of blue staining were then 
analyzed for mms6 expression with RT-PCR and Western blot. Then, mms6-positive 9L 
clones were imaged with MRI. The percent decrease in the value of T2 was used as a 
measure of MRI contrast. The larger the decrease, the greater the contrast. The positive 
clone number 4, whose row in the table has been highlighted yellow, was named 9L4S 












1  1  N       
2  3  Y  Y  32.1% 
3  1  N       
4  4  Y  Y  37.5% 
5  1  N  N    
6  3  Y  Y  30.9% 
7  2  Y  N    
8  2  Y  Y  24.6% 
9  2  Y  N    
10             
11  1  Y  Y    




24 clones with the highest amount of Prussian blue staining, a stain that indicates the 
presence of iron, were analyzed for gene expression with RT-PCR. RT-PCR analysis 
confirmed that 20 out of 24 clones were expressing mms6 and that the wild-type cells 
were not (Table 1 and Table 2). Western blot analysis confirmed that 14 out of 20 clones 
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number 4 was named 9L4S and selected for further study. The 9L4S clone expresses the 




2.5 Discussion & Conclusion 
 
Our primary objective was to create stable clones expressing mms6 and magA. Using 
standard molecular cloning techniques, we succeeded in making several dozen clones. 
We selected Prussian blue staining as the screen we would use to identify mms6-positive 
clones that showed increased levels of intracellular iron stain compared to wild-type 
cells. We selected Prussian blue staining because it is a sensitive, high-throughput, quick, 
and inexpensive assay, especially when compared to in vitro imaging, which we could 
have used to search directly for the clones that produce the most in vitro contrast. When 
we viewed the cells under a microscope, we expected to see both the positive and 
negative cells stained blue because all cells naturally take up iron because they need it to 
live (51). Relative to the wild-type cells, we also expected the positive cells to be stained 
more intensely because that would be consistent with our hypothesis that Mms6 enables 
cells to take up more iron than the wild-type cells. After staining the cells, we visually 
inspected the cells under the microscope and selected the clones that looked like they had 
been stained the most, both in terms of the number of cells that were stained and of the 
intensity of the iron stain. Though Prussian blue is a qualitative technique, relative 
differences in the intensity of the stain were significant enough that we were able to see 
that some clones were stained more than others, which indicated to us that they were able 
to take up more iron than the others. The fact that we were able to find evidence that at 
least some of the positive clones were able to take up more iron than the wild-type cells 
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alleviated a major concern. We knew that there existed a possibility that the transgene 
would not retain its ability to produce a functioning protein in a host cell or that it would 
express a protein that did not produce the phenotype in the cells that we expected, i.e. the 
uptake of iron. This is always a risk when expressing a transgene, especially if the gene is 
taken from one species and transferred to another.  
 
After RT-PCR and Western blot analysis, our next objective was to determine whether 
the clones could produce MRI image contrast. We found that magA-positive clones could 
not produce any contrast, and that mms6-positive clones could. Importantly, mms6-
positive clones required cell culture media that was supplemented with iron in order to 
produce contrast. That posed a potential problem because we planned to image the 
positive clones in vivo. We were concerned that the clonal cells would not have access to 
enough iron in situ to produce image contrast.  
 
Multiple different cell lines were transfected with magA, and several dozen magA clones 
were made. Because there were slight differences in their nucleotide sequences, the magA 
genes from two different magnetotactic species were used for transfection. RT-PCR and 
Western blot analysis confirmed that the magA was indeed expressed in the clones. 
Despite repeated transfection attempts and careful examination of our cell culturing 
technique and imaging protocol, no statistically significant difference between the 
average T2 value of magA-positive clones and the average T2 value of the host cells was 
found. These results are not consistent with previous research which found that magA-
positive cells produce MRI contrast (49, 52). We concluded that magA was not able to 
function as an MRI reporter gene in 9L cell, 293T cells, and Hepa 1-6 cells. Because no 
magA-positive clone was used for further study, from this point forward, this dissertation 
will only focus soley on the study of mms6-positive clones. 
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Both transiently transfected mms6-positive cells and stable mms6-positive clones 
produced MRI contrast, as measured by comparing the T2 percent change of the clones 
with the T2 percent change of the host cells. Through a process of elimination, we 
successfully identified one clone with the greatest T2 percent change. That clone, which 
we named 9L4S, is an mms6-positive 9L clone. The T2 percent change of the 9L4S cells 
was -37.5%. In comparison, the T2 percent change of the 9L cells, which are mms6-
negative, was approximately -10%. We concluded that mms6-positive clones could 
produce MRI contrast. The 9L4S cell line was expanded for use in subsequent 
experiments. 
 
The maintenance of stable clones presents a challenge that could impact any future 
experimental use of 9L4S cells. The concern is that stable clones are only genetically 
stable for a limited amount of time, becoming less stable with each round of cellular 
division (53, 54). As the cells gain a growing number of mutations, the instability 
manifests itself in various forms, such as changes in cell morphology, in growth rate, in 
gene expression levels, and in chromosomal number. Some changes can be monitored 
under the microscope but unfortunately others cannot. Because experiments should not be 
performed with unstable cells, we took precautions to ensure that the cells we were 
working with had not been passaged for too long (55). These precautions consisted of 
keeping track of how times the cells being used for experimentation had been passaged, 
or subcultured. Clones that had been passaged for several months were discarded. 
Because we wanted to avoid having to make new clones, immediately after creating a 
clone, we took a fraction of the zero-passage cells and stored them in liquid nitrogen for 
future use. After expanding the remaining zero-passage cells, we also froze early-passage 
cells. If we had run out of clonal cells, we would have had to create more stable clones. 
As another precaution, the cells were visually inspected under the microscope every few 
days to make sure their morphology had not changed. 
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The transfection process itself could also have altered the normal function of the cell, for 
example, by causing the methylation of genes adjacent to the transgene or by mutating a 
native gene during the random insertion of the transgene into the host genome (56-59). 
Thus, soon after the clones were isolated, we discarded any clone that had a significantly 
different replication rate than that of the wild-type cells, as well as any clones that 
showed significant morphologically changes. To clarify, we only excluded clones that 
were significantly different from wild-type cells because we cannot assume that Mms6 
does not itself cause a change in replication rate or a change in morphology. In fact, since 
we know that iron is toxic to cells and causes cell damage (51, 60) and because we have 
evidence that positive clones take up more iron than wilt-type cells, it is within reason to 
assume that the clones’ morphology and growth rate might be altered due to the 
expression of mms6. 
 
When lipofection is used to transfect a batch of wild-type cells, the lipofection does not 
transfect 100% of the cells. This is a concern because the MRI signal produced by a 
heterogeneous group of positive cells, i.e. composed of a mix of positive and negative 
cells, is weaker than the signal produced by a homogenous group of positive cells. 
Moreover, though our objective was to measure the NMR signal produced by transfected 
cells, due to MRI’s low sensitivity, we did not expect to be able to detect the MRI signal 
produced by single cells. Since we wanted the positive clones to produce as much 
contrast as possible, we needed to create and maintain a homogenous group of positive 
cells. As explained in the methods section of this chapter, to create a homogenous group 
of cells, transfected cells were subject to two rounds of single cell cloning. To maintain a 
homogenous group of positive cells, the positive cells were engineered to express an 
antibiotics resistance gene.  
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CHAPTER 3  
 
MEASUREMENT OF MRI CONTRAST PRODUCED BY MMS6-
POSITIVE CLONES IN VITRO AND CHARACTERIZATION OF 
CELLULAR IRON UPTAKE 
 
After we succeeded in detecting contrast produced by our positive cells at 3 T, we 
conducted a series of in vitro studies on a single mms6-positive clone. Even though our 
goal was to determine whether positive clones can enhance MRI contrast in vivo, the 
mms6-positive clone was first studied in vitro for the following reasons: First, the in vitro 
experimental designs were easier to carry out, cheaper to achieve, and faster to complete 
than the in vivo experimental design. Second, detecting contrast produced by cells in vitro 
is much easier than detecting contrast produced by cells growing in a biological tissue. 
Third, it is easier to execute a controlled experiment in vitro. Cells growing inside a 
living creature respond to and are affected by physical, chemical, and biological changes 
in its local environment, changes that are often beyond the control of the researcher but 
that may affect the outcome of the imaging experiment. In contrast, it is much easier to 
control the cell growth conditions in vitro. 
 
For the in vitro experiments, we chose to focus our attention on only one positive clone. 
Because we planned to establish a tumor animal model using the same positive clones 
used for the in vitro studies, only positive clone derived from 9L cells were considered 
for further study. 9L cells were chosen from among the other options because they had 
already been used successfully by other researchers to make the same tumor animal 
model we were interested in making (61). Not only are 9L4S capable of producing 
tumors in vivo, 9L4S cells produced the most image contrast out of all the positive clones 
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that were created,. The mms6-positive 9L cells used for the studies described in Chapter 3 
and Chapter 4 is a positive clone named 9L4S. 
 
During the screening process described in Chapter 2, 9L4S was identified as an mms6-
positive clone that produced MRI image contrast when imaged in a 3 T scanner after 
being grown for three days in cell culture medium supplemented with 200 µM of iron. 
For Aim 2, the 9L4S cells were used in additional in vitro imaging studies. For instance, 
the 9L4S cells were imaged in a 9.4 T scanner. Several batches of 9L4S cells were also 
imaged in a 3 T scanner after each batch of cells was cultured in cell culture medium 
containing a different concentration of iron.  
 
Although Mms6 was an iron-binding protein in magnetotactic bacteria, we could not be 
certain how the recombinant protein would interact with iron in the cells that we had 
transfected. Even so, the possibility existed that if Mms6 could bind iron in the 9L4S 
cells, the amount of intracellular iron might increase in those cells. 9L4S cells were used 
to test the hypothesis that the change in MRI image contrast produced by 9L4S cells 
compared to the contrast produced by 9L cells might be due to a corresponding change in 
intracellular iron levels. An electron microscope was used to search for evidence of 
increased intracellular iron stores, and emission spectroscopy was used to measure the 





As discussed in Chapter 2, if the protons in two adjacent tissues have different T2 
relaxation times, contrast between the tissues on an MRI image can be generated by 
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making the different relaxation times correspond to different signal intensities in a T2-
weighted MRI image. If the expression of an MRI reporter gene in one of those two 
tissues changes the transverse relaxation time of that same tissue such that the numerical 
difference between its relaxation time and the relaxation time of the adjacent tissue 
increases, then the contrast between the two tissues on a T2-weighted MRI image also 
increases. To change the transverse relaxation time of a tissue in which an MRI reporter 
gene is expressed, the MRI reporter gene must express a protein whose function within 
the cells leads to a change in transverse relaxation. In the case of mms6, we hypothesized 
that the difference between the T2 value of 9L4S cells and the T2 value of 9L cells was 
due to an increase in intracellular iron brought about by the expression of mms6. A brief 
discussion on the effects of iron on the transverse relaxation of neighboring protons will 
now be presented: 
 
3.1.1 The Effects of Iron on Transverse Relaxation 
 
MRI detects the magnetic perturbations of magnetic nuclei of specific elements (62). 
Because of its relatively high sensitivity, its magnetic properties, and its natural 
abundance in living organisms; hydrogen is the element whose magnetic dipole moment 
is most frequently manipulated and measured (7). Because iron is a superparamagnetic 
element, when it is found in an object, iron atoms will become a local source of magnetic 
field variation (13). Since local magnetic fields alter the magnetic dipole moments of 
atoms, including hydrogen, located within that field, magnetic elements are able to alter 
the NMR signal and the image contrast. Because iron is one such magnetic element, iron 
has been used as an MRI contrast agent in tissue-specific imaging and molecular imaging 
(63). Iron-based contrast agents can be characterized by their T2 relaxation times because 
the local field variations produced by iron shorten the T2 relaxation times of adjacent 
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atoms, including hydrogen. In T2-weighted images, iron particles produce areas of 





3.2.1 In Vitro MRI 
 
After the 9L4S clone were chosen for all future experimentation, we began by more 
thoroughly investigating the MRI contrast generated by the 9L4S cells. When the 9L4S 
cells were imaged during the selection process described in Chapter 2, cells were 
incubated for three day with media containing 200 µM of iron. A total of four cell 
samples (N = 4) were imaged, and the imaging study was not repeated. To make sure that 
the imaging results were reproducible, the same imaging experiment was repeated 6 
times over the course of 15 days. Please refer to the Approach section in Chapter 2 for 
more details. The experimental design of the imaging study is based on methods 
previously established by other members of our lab (49). The T2 values of all the cell 
samples were averaged (N=24). For dosing studies, we varied the concentration of iron in 
the cell culture media to determine how much in vitro contrast the cells would produce 
when incubated with iron concentrations less than 200 µM of iron. This was important 
because when we used the 9L4S cells to establish an animal model, the cells would be 
exposed to a pool of iron with significantly less than 200 µM of iron, i.e. the iron in the 
blood (64, 65).  
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3.2.2 Prussian Blue Staining 
 
Since the 9L4S cells produced changes in the relaxation rates, we wanted to investigate 
the intracellular iron content of the cells. We began by confirming that 9L4S cells stained 
with Prussian blue had a greater number of blue deposits than the host cells, which are 
the 9L cells. Prussian blue staining is a standard technique used to stain for iron presence 
in fixed, whole cells. Prussian blue staining involves fixing the cells on a culture dish and 
treating the cells with potassium ferrocyanide and with hydrochloric acid to release ferric 
ions from iron binding protein. A histochemical reaction occurs when any ferric iron 
(Fe3+) present in the cells combines with ferrocyanide and results in the formation of 
ferric ferrocyanide, a blue pigment called Prussian blue that is visible under a microscope 
(66). Blue deposits seen in the cells indicate that iron is present; the more deposits that 
are seen, the more iron that is present. Even though Prussian blue is a qualitative 
technique, from experience we knew that a difference in the number of blue deposits in 
the positive cells and the number of blue deposits in the control cell, i.e. 9L cells, was 
clearly visible.  
 
3.2.3 Intracellular Iron Measurement 
 
To support the results of the Prussian blue staining, we wanted obtain a qualitative 
measure of the amounts of iron stored in 9L4S cells and 9L cells; so we cultured 9L and 
9L4S cells for three days with media containing 200 µM iron, which was the same 
amount of time and the same concentration of iron that was used in the imaging studies. 
The cells were collected in a tube and sent to a chemical analysis laboratory. A type of 
emission spectrometry technique called ICP-OES was used to measure the iron content of 
our cell samples. ICP-OES uses inductively coupled plasma to heat the sample to 
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temperatures high enough to excite atoms and ions in the sample and causing each 
element in that sample to emit light. Since each element emits light of a particular 
wavelength, an element’s presence in the sample can each be identified when its 
wavelength is detected. In addition, the concentration of an element in the sample can be 
calculated by measuring the intensity of the light emitted at that element’s characteristic 
wavelength (67, 68). ICP-OES measures the relative concentration of trace elements in a 
sample. Specifically, it is used to measure how many µg of an element are found in every 
gram (g) of sample, i.e. parts per million (ppm). For instance, in our case, after drying the 
cell samples we sent them, they used ICP-OES to measure how many µg of iron were 
found in every g of dried cells.  
 
3.2.4 Transmission Electron Microscopy 
 
Because we had evidence that the 9L4S cells contained more iron than the control cells, 
we wanted to look at the distribution of iron within the cells. After being cultured with 
200 µM iron for three days, we sent 9L and 9L4S cells to an electron microscopy 
laboratory where a technician prepared the clones for viewing under a transmission 
electron microscopy. Transmission electron microscopy (TEM) is a microscopy 
technique used to view the ultrastructure of a specimen after it has been sliced down to a 
thickness of approximately 70 nm. When an electron beam of uniform current density is 
transmitted through the specimen, the electrons interact with atoms in the specimen and 
scatter (69). An image is then captured of the electrons as they pass through to the other 
side of the sample. After our cells were prepared for viewing, we searched both the 9L4S 
cells, or mms6-positive cells, and the 9L cells, or mms6-negative cells, for evidence of 
intracellular iron under the microscope.  
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3.2.5 Trypan Blue Dye Exclusion Assay 
 
The integration of a transgene into the host genome and the expression of a foreign 
protein in the host cell can sometimes alter cell viability and cell growth. We thus wanted 
to track cell growth and cell viability of the 9L4S clones over the course of 6 days and 
compare them to the cell growth and cell viability of the 9L cells. From amongst several 
options (70), we selected the Trypan blue dye exclusion test. The Trypan blue dye 
exclusion assay involves counting the number of cells that prevent the Trypan blue dye 
from passing through their cell membranes and into their cytoplasms. The assay entails 
adding the Trypan blue to a suspension of cells and counting the number of blue and clear 
cells. Since live (viable) cells possess intact cell membranes that prevent the dye from 
crossing their cell membranes and dead (non-viable) cells do not, tracking the number of 
blue and clear cells over a period of time is used to measure cell viability (71). 
 
For the Trypan blue dye exclusion assay, a small number of cells were seeded on a plate 
and given time to replicate until the cells were confluent. To track how fast the cells were 
replicating, the number of cells growing on the plate was counted periodically. In 
summary, cells were seeded such that the cells, if they were allowed to grow for 6 day 
period, would be confluent on day 6 day. To track cell growth, every day for a period of 6 
days, the cells were exposed to trypan blue dye. Using a hemocytometer, the cells were 
visually examined under a microscope. The number of blue cells and the number of clear 
cells were counted. Cell growth was examined with a graph of the number of live cells 
(clear cells) present on the cell culture plate vs time. The cell growth of both the 9L and 
9L4S cells was monitored. The percent cell viability could also be calculated using the 
same data. The percent cell viability was calculated by dividing the total number of live 
cells (clear cells) by the total number of cells (blue plus clear cells) and multiplying that 
number by 100. The percent cell viability for both the 9L and 9L4S was calculated for 
 77
each of the 6 days. We then graphed the percent cell viability of the cell samples for each 
of the 6 days.  
 
3.2.6 MTS Assay 
 
Iron overload can lead to cell toxicity. Since our studies involve culturing cells with iron, 
it was important to determine how iron affects the viability of the cells and to determine 
if iron affected the cell viability of 9L cells more than 9L4S cells, or vice versa. Several 
viability assays exist, each of which measures cell viability on the basis of different 
biological principles (70). The viability assay we chose is called the MTS (3- (4,5-
dimethylthiazol-2-yl)- 5-(3-carboxymethoxyphenyl)- 2-(4-sulfophenyl)-2H-tetrazolium)  
assay. The assay involves tracking the mitochondrial activity of a group of cells. 
Specifically, dehydrogenase enzymes located in the mitochondria convert MTS into 
formazan crystals, and the assay is used to measure the amount of formazan crystals 
produced by the enzymes. Since the detection of mitochondrial activity is indicative of 
cell viability, the detection of formazan crystals made by a group of cells is used as a 
measure of cell viability. Because enzymes require time to form the formazan crystals, 
the number of formazan crystals produced by live cells increases over time (72). The 
MTS assay entails spectrophotometrically measuring the number of formazan crystals 
produced by cells growing in a culture dish over a period of 1 to 4 hr. 
 
We assayed 9L and 9L4S cultured in media with five different iron concentrations, for a 
total of 10 different samples. The samples were prepared in triplicate, bringing the total 
number of samples to 30. We began by plating enough 9L and 9L4S cells such that the 
cells became ~90% confluent after a period of three days. After three days, MTT was 
added directly to the cell culture medium and then left for a few hours in order to give the 
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mitochondrial enzymes time to convert the MTT to formazan. After the formazan was 
solubilized in the culture medium, the concentration of formazan was determined by 





3.3.1 Cell Culturing 
 
Please refer to the methods section of Chapter 2, subsection 2.3.1 Cell Culturing. 
 
3.3.2 In Vitro MRI at 3 T 
 
9L cells were seeded in 24 plates, and 9L4S cells were seeded in another 24 plates. For 
each cell line, 12 of the plates contained cell culture media supplemented with enough 
ferric citrate to make the concentration of iron in the media 200 µM. In the other 12 
plates, the cell culture media contained no iron supplement. After three days in the 
incubator, the cells had grown to ~90-95% confluency in 100 mm plates. The culture 
media was removed from the plates, and the cells were washed with PBS. To detach the 
cells, 1 ml of trypsin EDTA was added to each plate. After five min, 3 ml of cell culture 
medium was added to each plate. The 12 plates were divided equally into 4 groups, 3 
plates per group. The cells from each group were combined and put into separate 10 ml 
tubes. The cell solution was centrifuged for 5 min at 1,000 rpm. The supernatant was 
removed, and the cell pellets were resuspended in 1 ml of PBS and placed into separate 
1.5 ml tubes. The cells were then given time to settle by gravity for two hr and 20 min at 
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4 °C. The cell pellets were imaged at 3 T. For details about the 3 T MRI scanner and the 
imaging parameters, please refer to the methods section of Chapter 2, subsection 2.3.7 In 
Vitro Imaging. Once the T2 values were measured, the transverse relaxation rates or 







In total, 16 samples were imaged at once: 4 samples of 9L cells cultured with an iron 
supplement, 4 samples of 9L cells cultured without an iron supplement, 4 samples of 
9L4S cells cultured with an iron supplement, and 4 samples of 9L4S cells cultured 
without an iron supplement. After imaging, the 16 cell pellets, or samples, were stored at 
-20 °C. This imaging experiment was repeated 6 separate times on 6 separate days such 
that number of samples (N) per experimental condition was 24.  
 
For the iron dosing experiment, 9L cells were seeded in 144 plates, and 9L4S cells were 
seeded in another 144 plates. For each cell line, the 144 plates were divided into 6 groups 
of 24 plates. Each of the 6 groups contained cell culture media with a different 
concentration of iron: 0, 50, 100, 150, 200, or 250 µM. The cells were prepared as 
described above. Since the cells from 3 plates are combined to make one sample, each 
group of 24 plates resulted in 8 samples (N = 8). The relaxation rates of the 8 samples 
were averaged. Data are represented in a bar graph as means, and error bars are ± 
standard error of the means. 
 
3.3.3 In Vitro MRI at 9.4 T 
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8 plates of 9L cells and 8 plates of 9L4S cells were cultured with cell culture media 
supplemented with ferric citrate such that the concentration of iron in the media was 200 
µM. Another 8 plates of 9L cells and 8 plates of 9L4S cells were cultured with cell 
culture media with no iron supplement. After three days in the incubator, the cells had 
grown to ~90-95% confluency in the 100 mm plates. The cells were detached from the 
plate with trypsin. The cells from each plate were collected and placed into separate 
tubes. The cell solution was centrifuged for 5 min at 1,000 rpm. The supernatant was 
removed, and the cell pellets were resuspended in 1 ml of PBS and transferred to separate 
1.5 ml tubes. The cells were then given two hr to settle by gravity at room temperature. 
The cell pellets were imaged at 9.4 T. The number of samples (N) per experimental 
condition was 8. In total, 32 samples were imaged: 8 samples of 9L cells cultured with an 
iron supplement, 8 samples of 9L cells cultured without an iron supplement, 8 samples of 
9L4S cells cultured with an iron supplement, and 8 samples of 9L4S cells cultured 
without an iron supplement.  
 
The cell pellets were imaged in a 9.4 T Bruker BioSpec® 94/20 small animal scanner 
(Bruker, Billerica, MA, USA) with an MSME spin echo sequence. The following 
imaging parameters were used: TR = 4,000 ms, TE = 9.3-111.6 ms, Echoes: 12, and slice 
thickness = 1 mm. The transverse relaxation times (T2) of the cell pellet were calculated 
by fitting a decay curve to the signal produced from the MSME sequence. The transverse 
relaxation rate (R2) of a cell pellet was calculated using Equation (24). Image processing 
and analysis were performed using MATLAB and Excel. For in vitro experiments, three 





Statistical analyses were performed in Microsoft Excel 2010. An unpaired, two-tailed 
Student’s t-test was used to calculate a p-value. A p-value of less than 0.05 was 
considered to be statistically significant. 
 
3.3.5 Prussian Blue Staining 
 
Please refer to the methods section of Chapter 2, subsection 2.3.4 Prussian Blue Staining.  
 
3.3.6 Intracellular Iron Measurement 
 
The day after the final day of imaging at 3 T, all cell pellets were thawed, and all cells 
that had been cultured under the same growth conditions were combined in the same 
tube. Four tubes each contained one of the following: 24 imaging samples of 9L cells 
cultured with an iron supplement, 24 imaging samples of 9L cells cultured without an 
iron supplement, 24 imaging samples of 9L4S cells cultured with an iron supplement, and 
24 imaging samples of 9L4S cells cultured without an iron supplement. Recall that every 
imaging sample was a mix of cells that had been cultured in three 100 mm cell culture 
plates, so each tube contained cells cultured in 72 cell culture plates. The four tubes were 
packed with ice bags and shipped overnight to the Chemical Analysis Laboratory at the 
University of Georgia (UGA, Athens, GA, USA) for ICP-OES analysis. The cells in each 
tube made up a single sample for intracellular iron measurement. First, the four cell 
samples were freeze dried. 0.25 g of dried cells was weighed out into crucibles and ashed 
at 500 °C for 4 hr. After they cooled, 2 ml of aqua regia was added to each cell sample, 
and the four samples were analyzed with ICP-OES. 
 
 82
3.3.7 Transmission Electron Microscopy 
 
9L and 9L4S cells were cultured each cultured for three days with cell culture media 
supplemented with enough ferric citrate to make the iron concentration of the media 200 
µM. The cells, still attached to the cell culture plate, were then sent for viewing under a 
transmission electron microscope located in the Robert P. Apkarian Integrated Electron 
Microscopy Core of Emory University. Whole cells were prepared by a microscopy core 
technician as follows: For examination under the electron microscope, monolayer cells 
cultured on glass coverslips were fixed overnight with 2.5% glutaraldehyde in 0.1 molar 
(M) cacodylate buffer (pH 7.4) at 4 °C. Cells were then washed with the same buffer and 
post-fixed with 1% buffered osmium tetroxide, dehydrated through a graded ethanol 
series to 100%, and embedded in Eponate 12 resin (Ted Pella, Redding, CA, USA). 
Ultrathin sections were cut on a Leica UC6rt or UltraCut ultramicrotome (Leica 
Microsystems, Bannockburn, IL, USA) at 70 nm and counter-stained with 4% aqueous 
uranyl acetate and 2% lead citrate. Sections were examined using a JEOL JEM-1400 
(JEOL USA, Peabody, MA, USA) transmission electron microscope equipped with 
Gatan US1000.894 Ultrascan and SC1000.832 Orius CCD cameras (Gatan, Pleasanton, 
CA, USA). 
 
3.3.8 Trypan Blue Dye Exclusion Assay 
 
The Trypan blue dye exclusion assay was used to measure cell growth and cell viability 
of 9L and 9L4S cells incubated in cell culture media with no iron supplementation. For 
each cell line, 24 plates were seeded with 2.5 105. Enough cells were seeded such that 
the cells in each plate, if given the time, would be ~95% confluent in 6 days. 1 day later, 
the cells from 3 plates were trypsinized and re-suspended in culture medium. A small 
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volume of the cell solution was mixed with an equal volume of trypan blue (Invitrogen). 
The cells from the 3 plates were prepared and counted separately. Using a 
hemocytometer (Hausser Scientific, Horsham, PA, USA) and a brightsfield microscope, 
the number of blue stained cells and the number of unstained cells in each of the three 
plates were calculated and averaged. For each cell line, cell viability was calculated using 
the following equation:  
 
	 	 % 100	 	
	 	 	 	




This procedure was repeated every day for an additional five days. Because the number 
of living cells, i.e. the number of unstained cells, was counted every day for a period of 6 
days, cell growth was evaluated by graphing the number of living cells measured on a 
given day vs. the day on which the number of cells was counted. The data are presented 
as means ± standard deviation of the means. 
 
3.3.9 MTS Assay 
 
The CellTiter 96® AQueous Cell Proliferation Assay (Promega, Madison, WI, USA) was 
used to evaluate the cell viability of 9L4S and 9L cells using the manufacturer’s 
instructions. In short, cells were cultured in a clear 96-well plate. Each well was seeded 
with 103 cells cultured with 100 µl of medium. The cell culture media was supplemented 
with enough ferric citrate such that the concentration of iron in the media was 0, 50, 100, 
200, or 400 µM. These five concentrations of iron constitute the 5 experimental 
conditions. Because two cell lines were being assayed, there were a total of 10 different 
cell samples. To obtain an average, 3 of each of these unique cell samples were prepared, 
with one sample per well. After 3 days of incubation, 20 µl of CellTiter 96® AQueous 
 84
reagent (Promega, Madison, WI, USA) was added to each well and incubated for an 
additional 2 h at 37 °C. The absorbance at 490 nm was measured using the plate reader. 
Each of the 30 samples was measured 4 times. The data are presented as normalized 
means ± standard deviation of the measurements. For each of the 10 different cell 
samples, the cell viability of each of the 10 different cells samples was calculated using 
the following equation: 
 
	 	 % 100	 	
	 	 	 	 	







Statistical analyses were performed in Microsoft Excel 2010. An unpaired, two-tailed 
Student’s t-test was used to calculate a p-value. A p-value of less than 0.05 was 





As described in Chapter 2, 9L4S was chosen as the mms6-positive 9L clone that would be 
used in all future studies. It was the clone that was able to produce the most in vitro 
contrast, as gauged by T2 measurements. In the in vitro experiments described in this 
chapter, 9L cells served as the negative control cells. The results of the RT-PCR assay 
and the Western blot assay confirmed that 9L cells do not express mms6.  
 
 85
9L and 9L4S cells were cultured for three days with culture media supplemented with 
enough iron to make the concentration of iron in the media 0 or 200 µM. The cell pellets 
were then imaged at 3 T with MRI. Another group of 9L and 9L4S cells were also 
cultured for three days with and without 200 µM of iron in the media. They were imaged 
at 9.4 T with MRI. We measured the average R2 value of 9L cells to the average R2 value 
of 9L4S cells at both 3 T and 9.4 T (Figure 8). Comparing 9L4S cells cultured with and 
without iron, there was a 56.8% increase in R2 at 3 T and a 123.0% increase in R2 at 9.4 T 
(both with p < 0.0001). In contrast, comparing 9L cells cultured with and without iron, a 
similar percent increase in R2 was not observed; the iron supplementation led only to a 
7.7% increase in R2 at 3 T and an 18.6% increase in R2 at 9.4 T. When the cells were 
cultured in media that had not been supplemented with iron, 9L4S cells showed only a 
0.3% decrease in R2 at 3 T and a 1.4% increase in R2 a 9.4 T compared to the R2 values 
of the 9L cells. In contrast, when cultured in media supplemented with iron, 9L4S cells 
showed a 47.5% increase in R2 at 3 T and an 87.6% increase in R2 at 9.4 T compared to 
the R2 values of the 9L cells (both with p < 0.0001). As a negative contrast agent, iron 
increases he relaxation rates of the local pool of protons. The finding that 9L4S cells 
cultured with iron have a greater R2 value than 9L cells cultured with iron is consistent 
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have a faster relaxation rate than 9L cells, we had reason to believe that the changes in 
relaxation rates were accompanied by changes in intracellular iron. It is important to note 
that when 9L and 9L4S cells are incubated with iron in the range of 0 to 50 µM, the R2 
values of the 9L and 9L4S cells did not differ much (Figure 9). This is significant 
because when the 9L4S cells were used to establish an animal model (see Chapter 4), the 
cells were exposed to an iron pool, i.e. the iron in the blood, with significantly less than 
50 µM of iron (64, 65). This topic will be revisited in Chapters 4. 
 
We wanted to know whether the production of contrast we were able to detect on an MRI 
image could be due to Mms6 binding iron and thereby enhancing the iron storing 
capacity of the mms6-positive cells. Importantly, we were not so much interested in 
researching the specific mechanism by which Mms6 could potentially be affecting the 
uptake, storage, or transport of iron; we were mostly interested in detecting whether or 
not the changes in contrast could be correlated to changes in intracellular iron levels. The 
results of the Prussian blue staining, mass spectroscopy, and electron microscopy confirm 
that 9L4S cells take up more iron then 9L cells. According to the mass spectroscopy 
measurements, 9L4S cells can take up 2.8 times more iron than the 9L cells. The results 
of the imaging and iron studies are consistent with the hypothesis that the recombinant 
protein Mms6 enables cells to take up more iron than wild-type cells. The MTS assay and 
the Trypan blue dye exclusion assay led us to conclude that the cell viability and cell 
growth of the 9L4S cells were no different than the cell viability and cell growth of the 
9L cells. The Trypan blue assay also showed that incubating cells with iron less than 200 
µM of iron decreases the cell viability of both the 9L and 9L4S cells to the same extent. 
At an iron concentration of 400 µM, the cell viability of the 9L4S cells was greater than 
the cell viability of the 9L cells—perhaps the 9L4S cells were better able to tolerate 
higher concentrations due to the ability of Mms6 to bind iron.  
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With the MTS cell proliferation assay, we expected to see a small decrease in cell 
viability when the cells were cultured with iron; of course, the greater the concentration 
of iron supplemented in the culture medium and the more days the iron is left in the 
medium, the greater the toxic effects on the cells. These are exactly the results that we 
observed. The results were also consistent with what we had hypothesized: that 9L4S 
cells would be less sensitive to the iron than the 9L cells because the toxic effects of the 
iron on the 9L4S cells would be mitigated by Mms6. If Mms6 were able to bind and 
chelate the iron, in theory, it should prevent the iron from decreasing the cell viability. 
 
The concern of genomic instability became more pronounced as we completed the work 
outlined in this chapter. We needed growing and dividing cells for our experiments, so 
we could not halt chromosomal instability by keeping the clones preserved in liquid 
nitrogen. As mentioned before, with every passage, cells become more unstable and may 
begin to produce phenotypic changes due to the instability. On occasion, we noticed that 
positive clones that had been passaged and imaged for many weeks began producing less 
image contrast, a phenomenon which we attribute to genomic instability. Our solution to 
this problem was to periodically image the clones to confirm that the MRI signal has not 








CHAPTER 4  
 
ESTABLISHMENT OF TUMORS COMPOSED OF POSITIVE 
CLONES IN AN ANIMAL MODEL AND MEASUREMENT OF THE 
MRI CONTRAST PRODUCED BY THE TUMORS 
 
The ability of mms6 to enhance the contrast produced by a particular cell is an ability that 
it must have in order for it to be considered an MRI reporter gene. With that in mind, we 
transfected cells with mms6, developed positive clones, and measured the T2 relaxation 
time of one of those mms6-positive clones, 9L4S. The MRI results at both 3 T and 9.T 
showed that in vitro, 9L4S cells produced more contrast than 9L cells; however, the 
overall purpose of our project was to examine the possibility that mms6 can be used as an 
MRI reporter gene in vivo. Based on the in vitro results, we then hypothesized that Mms6 
may also enable 9L4S cells to produce more image contrast in vivo than 9L cells, which 
do not express mms6. To test our hypothesis, we established tumors with different 
amounts of 9L and 9L4S cells in two different strains of rats. Once the tumors were 
established, we imaged the tumors with MRI once a week for up to three weeks. We 
discovered that tumors that developed from 9L4S cells do produce more negative contrast 
than tumors developed from 9L tumors, but only when the tumors are small. We also 
confirmed that the tumors developed from 9L4S cells had more iron deposits than the 
tumors developed from 9L cells. Finally, we found that giving the rats iron 
supplementation (10 mg of iron per 200 g of body weight) decreased the difference 






The final aim of our research was to determine whether mms6 would enable 9L4S cells to 
produce more MRI image contrast in vivo than 9L cells. In order to image the cells in 
vivo, the cells had to be introduced into an animal. We chose rats as the animal we would 
be using for our research. A brief description of the use of rodents in biomedical research 
now follows: 
 
4.1.1 Rodents in Biomedical Research 
 
Mammalian animals are used in biomedical research because of their close proximity to 
humans in terms of genetics, anatomy, and physiology. Among other things, they are 
used to study diseases and medical conditions, to develop treatments and vaccines, to find 
cures, and to test medical procedures before they are used on humans. Although 
monkeys, dogs, cats, cows, sheep, and even pigs have been used for research purposes, 
the rodent is the most commonly and widely used animal. Rodents are small in size and 
easy to handle, so it is relatively inexpensive to purchase and house them. Rodents breed 
quickly so large populations of rodents can be created, making rodents readily available 
for research. In addition, inbreeding has led to the creation of genetically homogenous 
populations of rodents, which is an added benefit to researchers who want to execute a 
controlled experiment. Although mice are by far the most commonly used animal model 






4.2.1 Tumor Animal Model 
 
At the cellular level, MRI reporter genes enable cells located inside a living organism to 
be visible via MRI. Because we wanted to determine whether mms6 can be used as an 
MRI reporter gene in vivo and because we had confirmed that 9L4S cells have greater 
image contrast than 9L cells in vitro, we implanted 9L4S cells inside an animal to 
determine if 9L4S are also able to produce more contrast than 9L cells in vivo. In 
particular, we established tumors that grew out of inoculations of 9L and 9L4S cells. We 
chose to use a tumor model for a few reasons. For starters, it is a model created with 
established techniques. In addition, when cells form tumors, they stay together as a 
group. Together the cells can produce more contrast than they can apart, so the tumor is 
more likely to stand out in an MRI image from among the endogenous tissue which 
surrounds the tumor. As an added benefit, the location of the tumor could be controlled 
simply by grafting the cells at the exact location where we wanted the tumor to grow. 
Since we knew where we had implanted the cells, we were able to easily find the tumors 
during imaging. 
 
To create a tumor model, a tumor composed of mms6-positive clones is established in an 
animal via injection of the clone at the desired location of tumor formation. Though we 
had several clones, we used 9L4S cells for tumor inoculations not only because 9L4S 
cells had the highest average relaxation rate in vitro, but also because 9L4S is an mms6-
positive 9L clone. 9L cells and clones derived from 9L cells are tumorigenic. If they were 
not, 9L and 9L4S cells would not form tumors once they were grafted in an animal. 9L 
cells are a gliosarcoma cell line. Gliosarcoma is a rare type of glioma; and a glioma is a 
type of malignant brain tumor that arises when glial cells mutate and become cancerous. 
When 9L cells were selected as host cells for transfection with mms6 at the start of the 
research project, 9L cells had already been used to grow brain and flank tumors (61, 73). 
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With all that in mind, we chose to begin our animal studies with the creation of a flank 
tumor animal model. Establishing subcutaneous flank tumors involved an easy and quick 
procedure whereby the animal were first anesthetized and then injected subcutaneously 
with a cell suspension into the flank. Both 9L and 9L4S cells were implanted into the 
flank of a single rat, with 9L cells on one side and 9L4S cells on the other, thereby 
reducing the total number of animals required for experimentation by half. 
 
Our species of choice was rats. We chose rats over mice mainly because of their larger 
size. Bilateral injections were easier to perform because of the rat’s larger size. 
According to the experimental guidelines to which we had to abide (refer to the 
Appendix, section A.2 Animal Use), animals had to be euthanized if a tumor grew too 
large relative to its body size. The rat’s larger body size allowed tumors to grow larger 
before they hindered the rat’s movements or affected the rat’s health. At the time, we 
wanted to grow larger tumors because we thought that the larger tumors would produce 
better image contrast than the smaller tumors. In addition, larger tumors required 
additional time to grow, giving us the opportunity to track any changes in MRI contrast 
for a longer period of time. We also reasoned that small tumors would require a higher 
spatial resolution in order to be visible on an MRI image than larger tumors would 
require. We elected to work with male rats not only because they are less expensive to 
purchase but also because we were advised by an experienced colleague that male rats are 
easier to handle than female rats. 
 
4.2.2 Iron Overload 
 
In vitro, we found that 9L4S cells required supplemental iron in order to increase their 
average relaxation rate. We later discovered that under specific circumstances, tumors 
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that grew from inoculations with 9L4S cells, or 9L4S tumors, also had faster relaxation 
rates than tumors that grew from inoculation with 9L cells, or 9L tumors. In these 
experiments, the flank tumors were exposed only to the endogenous iron located inside 
the body of the rat. Serum iron concentrations of rats are very low compared with the 
supplemental iron concentrations of our in vitro experiments (64, 65). We hypothesized 
that if rats received an iron supplement, the difference between the average relaxation 
rate of 9L4S tumors and the average relaxation rate of 9L tumors would increase 
compared to the difference between their relaxation rates when rats were not given any 
iron supplement. 
 
Iron overload in rats is often achieved via the administration of iron dextran. There are 
several methods used by other researchers to produce iron overload in rats using iron 
dextran. For instance, some researchers have administered i.p. (intraperitoneal) injections 
containing either 250 or 500 mg of iron per kilogram (kg) every other week for 22 weeks 
(a total of 900 mg of iron) (74, 75). Other researchers instead administered single doses 
containing 500 mg of iron per kg via i.v. (intravenous) or i.p. injections or 1,200 mg of 
iron per kg via s.c. (subcutaneous) injections (76-79). We chose to modify the 
experimental methods of a group of researchers who administered daily i.p. injections of 
100 mg of iron per kg for seven day to male F344 rats (80, 81). Using their method, the 
serum iron levels in the blood were 1032.3± 209.68 µM (80). Based on a preliminary 
study, we found that the rats did not tolerate such high doses of iron for that number of 
days. We also found that the relaxation rates of 9L and 9L4S tumors were basically 
identical. We thus chose to modify their experimental method. We would inject only 50 
mg of iron per kg for a period of five days.  
 
The animals were tumor inoculated as normal and then given 9 days to grow. On day 9, 
the animals were hand held and given up to 10 mg of elemental iron per 200 g of body 
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weight. The iron dextran was injected i.p. once a day for five days. The iron dextran 
solution came in a concentration of 100 mg/ml, so we would have injected a 130 g rat 
with 65 µl of iron dextran solution. The injections were given for five days so that the 
tumors had several days to take up iron from the blood stream. Based on a preliminary 
study, we knew that if the tumors took up too much iron, the relaxation rates of the 9L 
and 9L4S tumors would be the same; so we waited 24 hr after the last injection to image 
the tumors. The rats were imaged by MRI on day 14. 
 
4.2.3 In Vivo MRI 
 
Once tumors were established in the rats, the tumors were given two weeks to grow 
before being imaged with MRI. The animals were then imaged once a week for up to 
three weeks. The animals were scanned in a Bruker 9.4 T small animal MRI scanner with 
a T2-weighted spin echo sequence. To take advantage of magnetic susceptibility 
difference created by the iron, we could have used T2*-weighted gradient echo imaging. 
Both types of imaging have been used for imaging iron oxide labeled cells (10, 49, 82). 
We chose to use a T2-weighted spin echo sequence not only because the sequence can 
produce images with less image distortion and image artifacts (82), but also because we 
wanted to compare our imaging results to the results of a previously completed magA 
study (49). After we imaged our tumors, we used ParaVision 5.1, Bruker’s imaging 
software, to calculate the T2 relaxation times of the tumors. As with the in vitro imaging 
data, we converted the T2 values to R2 values and compared the average relaxation rates 
of the 9L tumors to the average relaxation rates of the 9L4S tumors.  
 
4.2.4 In Vitro MRI 
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At 3 T and in vitro, when the cells were incubated for three days with 50 µM of iron, the 
percent change in the relaxation rates of 9L and 9L4S cells was modest, only 15.5%. The 
iron in the blood of a rat is less than 50 µM, so we initially wondered whether we would 
be able to detect any differences in the relaxation rates of 9L and 9L4S tumors even if the 
tumors were imaged at a higher magnetic field strength (9.4 T). To determine whether the 
percent change in the relaxation rates of 9L and 9L4S cells would be significantly bigger 
when imaged at 9.4T, the in vitro imaging study of 9L and 9L4S cell pellets was 
repeated. The cells were incubated for three days with only 40 µM of iron instead of 50 
or 200 µM, and they were imaged at 9.4 T instead of at 3 T. In addition, to better mimic 
the conditions in the body of the rat, where the iron in the blood is replenished every time 
it eats, some of the cells were also incubated with 40 µM iron that was periodically 
replenished over the course of three days. 
 
4.2.5 Western Blot Analysis 
 
The rats were not given Zeocin, which was the antibiotic used to prevent mms6-negative 
cells from growing on cell culture plates containing 9L4S cells. Once the animals were 
inoculated with the cells, Zeocin would no longer maintain a pure cell line. After the cells 
were given a couple of weeks to replicate and form tumors and after the animals were 
imaged with MRI, we wanted to determine whether the tumor cells were still expressing 
mms6. Once the animal had been euthanized, whole flank tumors were excised. Western 
blotting was used to determine whether Mms6 was still present in the 9L4S tumor and to 
confirm that it was absent in the 9L tumor. 
 
4.2.6 H&E Staining and Prussian Blue Staining 
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When the relaxation rates of the tumors had been measured, we found that the average 
relaxation rate of the 9L4S tumors was faster than the average relaxation rate of the 9L 
tumors under certain conditions. We then wanted to determine whether the difference in 
relaxation rates between the 9L tumors and 9L4S tumors coincided with a difference in 
their intracellular iron contents. We also wanted to compare the morphology of the two 
tumors. We accomplished both of these goals with histological staining. Immediately 
after their last imaging sessions, the rats were euthanized, and their tumors were excised, 
fixed, sectioned, and stained. The tissue sections were then either stained with 
hematoxylin–eosin (H&E) to observe the morphology of the tumor cells or with Prussian 





4.3.1 Tumor Animal Model 
 
We established flank tumor models in 5-7 week old male rats: 14 male RNU Rats 
(Crl:NIH-Foxn1rnu) (Charles River, Wilmington, MA, USA) and 13 male F344 (SAS 
FISCH) Rats (F344/NCrl) (Charles River). First, 9L and 9L4S cells were collected from 
the cell culture plates and were each resuspended in 100 µl of PBS containing 10% 
Matrigel (BD Biosciences, San Jose, CA, USA). Rats were anesthetized by an 
intraperitoneal injection of ketamine (85 mg/kg)/xylazine (10 mg/kg). The hair on the 
lateral sides of the flank was shaved, and the injection site was disinfected with betadine 
and 70% alcohol. The cell solutions were then injected with a 23-gauge needle 
subcutaneously in the flank, immediately above the hind legs. All rats were tumor 
inoculated with 9L cells in the right flank and 9L4S cells in the left flank. 3 RNU rats 
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were tumor inoculated with 2 106 cells in each side of the flank, and another 3 RNU rats 
were tumor inoculated with 5 106 cells in each side of the flank. 8 RNU rats were tumor 
inoculated with 1 106 cells in each side of the flank. All 13 F344 rats were tumor 
inoculated with 1 106 9L cells in the right flank and 1 106 9L4S cells in the left flank. 
The animals were imaged with MRI for the first time two weeks later, after which time 
they were imaged with MRI once a week. The rats were imaged a maximum of three 
times.  
 
4.3.2 Iron Overload 
 
9 days after tumor inoculations, 4 of the F344 rats received 10 mg of elemental iron per 
200 g of body weight in the form of i.p. iron dextran injections (Vedco, St. Joseph, MO, 
USA) every day for a period of five days. The last day they received iron injections 
occurred 13 days after tumor inoculations. Starting the next day, i.e. 2 weeks after tumor 
inoculations, the rats were imaged with MRI for four consecutive days. 
 
4.3.3 In Vivo MRI at 9.4 T 
 
After the rats were given 2, 3, or 4 weeks to grow, anesthesia was induced with 5% 
isoflurane/95% oxygen and was maintained with 1.5-2% isoflurane. The small animal 
Model 1025 Monitoring and Gating System (SAII, Stony Brook, NY, USA) was used to 
monitor heart rate, body temperature, and respiratory rate during imaging. Rats were 
imaged on a heated cradle in a 9.4 T Bruker BioSpec® 94/20 small animal scanner 
(Bruker). After localization, a set of high-resolution T2*-weighted images were acquired 
for tumor delineation using fast low-angle shot (FLASH) with TE = 6.0 ms, TR = 50 ms, 
FOV = 256 mm  256 mm, in-plane resolution = 88 micrometers (µm), and slice 
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thickness = 0.450 mm. To create a T2-weighted image, an MSME spin echo sequence 
was applied with the following imaging parameters: TR = 4,000 ms, TE = 9.3-111.6 ms, 
Echoes: 12, FOV = 60 mm  60 mm, in-plane resolution = 0.5 mm, and slice thickness = 
1 mm. The image from the first echo was included in the figures as an anatomical map. 
Image processing and analysis were performed using MATLAB.  
 
During imaging, enough slices of the tumor were obtained to span the entire length of the 
tumor. We collected data from each rat, one tumor at a time, as follows: using a software 
called ParaVision 5.1 (Bruker), we obtained the average T2 value of each tumor slice and 
subsequently averaged those values to get the T2 value of the whole tumor. The 
transverse relaxation times (T2) are calculated by exponential fitting of a decay curve to 
the signal produced from the MSME sequence. Next, we averaged the T2 values of the 
individual 9L4S tumors and averaged the T2 values of the individual 9L tumors to obtain 
the average T2 value of the 9L4S tumors and the average T2 value of the 9L tumors. 
Finally, using Equation (24), the average T2 values of the tumors were converted to 
average R2 values of the tumors in Microsoft Excel 2010. The relaxation rates of the 
tumors were compared. The data are presented as means of the R2 values of the tumors ± 
standard error of the means. 
 
4.3.4 In Vitro MRI at 9.4 T 
 
9L cells were seeded in 27 plates, and 9L4S cells were seeded in another 27 plates. For 
each cell line, 18 of the plates contained cell culture media supplemented with enough 
ferric citrate to make the concentration of iron in the media 40 µM. In the remaining 9 
plates, the cell culture media contained no iron supplement. Out of the 18 plates that 
contained media with iron supplementation, the media in 9 of them was discarded and 
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replaced with fresh media containing 40 µM of iron every 12 hr. After three days in the 
incubator, the cells had grown to ~90-95% confluency in 100 mm plates. The culture 
media was removed from all the plates, and the cells were washed with PBS. To detach 
the cells, 1 ml of trypsin EDTA was added to each plate. After five min, 3 ml of cell 
culture medium was added to each plate. The 9 plates which had their cell culture media 
replaced every 12 hr were divided equally into 3 groups, 3 plates per group. The same 
was done with the 9 plates containing media with no iron supplementation and the 9 
plates containing media with iron supplementation that was not replaced every 12 hr. The 
cells from each group were combined and put into separate 10 ml tubes. The cell solution 
was centrifuged for 5 min at 1,000 rpm. The supernatant was removed, and the cell 
pellets were resuspended in 1 ml of PBS and placed into separate 1.5 ml tubes. The cells 
were then given time to settle by gravity for two hr and 20 min at 4 °C. The cell pellets 
were imaged at 9.4 T.  
 
For details about the 9.4 T MRI scanner and the imaging parameters, please refer to the 
methods section of Chapter 3, subsection 3.3.3 In Vitro MRI at 9.4 T. Once the T2 values 
were measured, the transverse relaxation rates (R2) of the cell pellets were calculated 
using Equation (24). In total, 18 samples were imaged at once. For both 9L and 9L4S, 3 
samples of cells cultured with an iron supplement, 3 samples of cells cultured with an 
iron supplement that was replenished every 12 hr, 3 samples of cells cultured without an 
iron supplement. The data are presented as means of the R2 values of the cell pellets ± 
standard error of the means. 
 
4.3.5 Western Blot Analysis 
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T-PER Tissue Protein Extraction Reagent (Thermo Fisher Scientific) was used for the 
extraction of total protein from the tumor tissue. For details about the Western blot 
protocol, please refer to the methods section of Chapter 2, subsection 2.3.6 Western Blot 
Analysis.  
 
4.3.6 H&E and Prussian Blue Staining 
 
Immediately after the rats were scanned for the final time, the rats were euthanized with 
CO2. Whole tumors were excised and submerged in an embedding matrix called Tissue-
Tek™ CRYO-OCT Compound (Fisher Scientific, Suwanee, GA, USA). The compound 
was solidified and the tissue was snap frozen on dry ice. The tissues samples were then 
sectioned (8 µm) and fixed with ice-cold acetone. The tissue sections were then either 
stained with hematoxylin–eosin (H&E) or with Prussian blue. In the latter case, a 
Prussian blue staining kit (Ocean NanoTech, Springdale, AR, USA) was used and the 
manufacturer’s instructions were followed. The tissue slices were examined under an 




Statistical analyses were performed in Microsoft Excel 2010. An unpaired, two-tailed 
Student’s t-test was used to calculate a p-value. A p-value of less than 0.05 was 
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after 3 weeks. The relaxation rates of the tumors were measured and averaged (Figure 
18g). Like before, the average R2 value of the 9L4S tumors was larger than the average 
R2 value of the control tumors at three weeks (p = 0.031). At two weeks, the average R2 
value of the 9L4S tumors were also larger (p = 0.0004). An R2 map of one of the rats was 
also generated to observe the R2 values across a single slice of the tumor (Figure 18a-f). 
The relaxation rates at the border of the tumor tended to be faster than the relaxation rates 
in the center of the tumor. 
 
To determine whether similar results would be obtained if a different strain of rat was 
used to create a tumor animal model, the same experiment was repeated with F344 rats. 
The relaxation rates of the tumors were measured and averaged (Figure 19g). The 
average R2 value of the 9L4S tumors was also greater than the R2 values of the 9L tumors 
at both 2 and 3 weeks after tumor inoculations (both with p < 0.0001). These results 
support our hypothesis that 9L4S tumors have faster relaxation rates than 9L tumors. An 
R2 map of one of the rats was also generated (Figure 19a-f). As in the RNU rats, the 
relaxation rates at the border of the tumor were generally faster than the relaxation rates 
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4.5 Discussion & Conclusion 
 
9L and 9L4S cells were used to tumor inoculate rats in the flank, with 9L cells injected 
into the right flank and 9L4S cells injected into the right flank. After allowing the cells to 
replicate for two weeks, the resulting tumors were imaged with MRI at 9.4 T and their 
relaxation rates were calculated. They were also imaged three and four weeks after tumor 
inoculations. When RNU rats were tumor inoculated with 1 106, 2 106, or 5 106 cells 
on each side of the flank; in any given week, rats that had been inoculated with more cells 
not only had tumors with slower relaxation rates, they also had larger flank tumors. For 
any of the three cell numbers used for tumor inoculation, with every passing week, the 
relaxation rates of the tumors also decreased. With every passing week, the tumors also 
got larger. Based on these results, we concluded that as tumors got larger, their relaxation 
rates decreased.  
 
We had hypothesized that 9L4S tumors would have faster relaxation rates than 9L tumors 
because 9L4S cells had faster relaxation rates than 9L cells in vitro. Interestingly, only 
RNU rats that had been inoculated with 1 106 cells had 9L4S tumors with faster 
relaxation rates than 9L tumors. This was the case at both 2 and 3 weeks after tumor 
inoculations. RNU rats are immunodeficient, so the tumors were able to grow larger in a 
shorter period of time. When we discovered that the relaxation rates were affected by 
tumor size and that 9L4S tumors only had faster relaxation rates than 9L tumors when 
they were small, we chose to work with a different rat strain. We chose to work with 
F344 rats because another group of researchers had successfully used F344 rats to 
establish flank tumor models (61). When we injected the F344 rats with 1 106 cells, at 2 
and 3 weeks, like the RNU rats, the 9L4S tumors had faster relaxation rates than 9L 
tumors. Furthermore, the difference between the average relaxation rate of the 9L4S 
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tumors and the average relaxation rate of the 9L tumors in the F344 rats was larger than 
the difference between the two average relaxation rates in the RNU rats. 
 
In the case of the F344 rats that had been inoculated with 1 106 cells, Western blot 
analysis confirmed that 9L4S tumors expressed mms6 and verified that 9L tumors did not 
express mms6. Prussian blue staining of tumors from the same rats showed that 9L4S 
tumors had more iron than 9L tumors. In contrast, after Prussian blue staining, we did not 
detect a difference in the levels of intracellular iron between the 9L tumors and the 9L4S 
tumors of RNU rats that had been inoculated with 2 106 cells These results support our 
hypothesis that 9L4S tumors have faster relaxation rates and more intracellular iron than 
9L tumors, although the results suggest that this is only true when the tumors are small. 
 
Though small 9L4S tumors had a faster relaxation rate than 9L tumors, we wondered 
whether giving the rats an iron supplement would increase the difference between the 
average relaxation rate of the 9L4S cell and the average relaxation rate of the 9L cells. 
We considered that in the body of the rat the serum blood iron concentration is less than 
50 µM (64, 65), whereas in vitro, the biggest difference between the relaxation rate of 9L 
and 9L4S cells occurred at 200 µM. We hypothesized that that the 9L4S cells would be 
able to take up more iron if the iron in the local endogenous iron pools was increased. To 
test this hypothesis, the rats were given iron injections; however no difference in the 
relaxation rates of the 9L and 9L4S tumors were detected. We propose that when the 
animals were given iron, too much iron was administered and both the 9L and 9L4S 
tumors were saturated with iron, so much so that no difference in relaxation rates could 
be detected.  
 
When the cells were imaged at 3 T in vitro for three days with 50 µM of iron, the 
difference between the average relaxation rate of the 9L cells and the average relaxation 
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rate of the 9L4S cells was only 15.5%. At 9.4 T, when the cell were imaged in vitro for 
three days with only 40 µM of iron, the difference between the average relaxation rates 
dropped to 10.3%. In contrast, the largest difference between the average relaxation rate 
of the 9L4S tumors and the average relaxation rate of the 9L tumors was 16.9% in the 
RNU rats and 34.9% in the F344 rat. The differences between the in vitro and in vivo 
results are most likely due to differences in how and where the cells grew over the course 
of the experiment. During the in vitro experiments, the clonal cells grew in a monolayer 
for three days with media that had been supplemented with iron but that was not 
replenished over the course of the three days. In contrast, in vivo, the cells grew into a 
tumor, which is 3D, for at least a couple of weeks; and each time the animal fed, the iron 
in its body was replenished. Unlike cells growing in cell culture dishes, the tumors 
became less homogenous over time because tumors activate an immune response as well 
as angiogenesis, evidence of which we found when we excised the tumors and saw the 
blood vessels that supplied the tumors with serum iron. As tumors grow, they also begin 
to necrotize. The heterogeneity of the cells was apparent on the MRI images. The 
imaging results showed that both the 9L and 9L4S tumors had hypointense and 
hyperintense regions visible on the same slice.  
 
Out of all these differences between the in vitro and in vivo growth conditions, we tested 
whether replenishing the 40 µM of iron in the growth media would affect the relaxation 
rates of the cells. When we replaced the growth media every 12 hours, the difference 
between the average relaxation rate of the 9L4S cells and the average relaxation rate of 
the 9L cells was 19.9% compared to a difference of only 10.3% when the media was not 
replenished. This suggests that replenishing the iron in the pool from which the cells take 
up iron increases the difference between the relaxation rates of the 9L and 9L4S cells. 
Interestingly, the average relaxation rate of the 9L cells was almost completely 
unaffected by replenishing the media. Based on the imaging studies and intracellular iron 
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measurements presented in Chapter 3, these results suggest that when 9L4S cells have 
access to iron that is replenished periodically, the 9L4S cells can take up more iron and 
thus have faster relaxation rates than 9L cells. Though we did not examine this line of 
study any further, perhaps there is a concentration of iron that is high enough so that even 
if it was replenished, 9L4S cells would not be able to take up any more iron and so its 
relaxation rate would not change.  
 
After imaging the animals and looking at the R2 maps, we noticed a trend: the relaxation 
rates on the edge of the tumor tended to be faster than the relaxation rates in the central 
part of the tumor (Figure 19f). This suggests that the cells do not take up iron uniformly. 
Perhaps the iron is not taken up uniformly because the intercellular iron pool is not 
evenly distributed throughout the tumor. This is likely considering tumors often have 
neither uniform vasculature nor equal perfusion of intercellular fluid (83-85). To compare 
the relaxation rates of heterogeneous tumors, we had to assume that on average, 9L and 
9L4S tumors developed similar vasculature and intercellular perfusion. If both tumors 
have the same degree of inhomogeneity, then the average relaxation rate of the 9L4S 






CHAPTER 5  
 
CONCLUSION AND FUTURE DIRECTIONS 
 
The project described in this dissertation is in the field of molecular imaging with MRI. 
Since we wanted to study MRI reporter genes, the project began by looking for genes that 
expressed a protein whose function might lead to the production of contrast in an MRI 
image. A literature review revealed that several genes had already been tested in vivo, in 
vitro, or both and thus might be good candidates for our molecular imaging project. 
These genes include β-galactosidase, tyrosinase, LRP, ferritin, and magA (5, 9, 10, 49, 
86-88). magA, a gene native to magnetotactic bacteria, was the first gene we selected for 
our research because we were interested in continuing the work pioneered in our lab, 
work which produced evidence that magA could be used in an imaging study requiring an 
MRI reporter gene. The magA protein, MagA, was considered a putative iron transporter. 
Due to the unique magnetic properties of magnetotactic bacteria, we then considered 
other genes native to magnetotactic bacteria. In the end, we selected two magnetotactic 
bacterial genes for use in our research, magA and mms6. We originally chose mms6 for 
our studies for two reasons. First, since previous studies of Mms6 showed that the protein 
could bind iron in the bacteria, we knew that mammalian cells transfected with mms6 
would express a recombinant protein that might be able to bind iron in the foreign 
intracellular environment of the mammalian cell. Based on the knowledge, we 
hypothesized that Mms6 would enhance the cells’ iron storing abilities. Second, if Mms6 
could increase the amount of intracellular iron, then we could co-transfect a cell line with 
both magA and mms6. In those cells, we hypothesized, MagA would transport iron into 
the cells, and Mms6 would bind the iron as it was being taken up by the cells. With the 
proteins working synergistically, cells expressing both genes would contain an even 
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greater amount of intracellular iron, more than the host cells and more than any cell line 
transfected with just one of the two genes. Importantly, we expected any increase in 
intracellular iron to correlate with an increase in MRI contrast. 
 
The principle objective of the work described in this dissertation was to determine if cells 
transfected with the genes mms6 or magA have more MRI image contrast than the wild-
type cells. To compare the image contrast of the cells, we measured their relaxation rates. 
We hypothesized that mms6-positive and magA-positive clones would have faster 
relaxation rates than wild-type cells. First, we engineered several dozen mms6-positive 
and magA-positive single cell clones. After we measured the contrast produced by the 
clones in vitro, we found that the difference between the relaxation rates of magA-
positive clones and wild-type cells was not statistically significant. In contrast, mms6-
positive clones had faster relaxation rates than wild-type cells, but only when the cells 
were cultured with iron supplemented cell culture media. The clone that was able to 
produce the most image contrast, an mms6-positive clone named 9L4S, was selected for 
further study (Aim 1, Chapter 2). Because iron is a negative contrast agent and because 
we knew Mms6 binds iron in magnetotactic bacteria, we then hypothesized that the 
enhanced contrast produced by 9L4S cells might be due to an increase in intracellular 
iron uptake. Prussian blue staining, electron microscopy, and optical emission 
spectrometry provided evidence to support our hypothesis (Aim 2, Chapter 3). Because 
9L4S cells had faster relaxation rates than 9L cells in vitro, we hypothesized that 9L4S 
cells would have a faster relaxation rate than 9L cells in vivo. Rats were tumor inoculated 
with 9L cells on the right flank and 9L4S cells on the right flank. Without requiring any 
exogenous iron supplement, MRI imaging showed that small but not large 9L4S tumors 
had faster relaxation rates than 9L tumors at both two and three weeks after tumor 
inoculations and in both RNU and F344 rats. Because of the increased intracellular iron 
found in 9L4S cells cultured with iron supplemented media in vitro, we hypothesized that 
 123
9L4S tumors would also have more intracellular iron than 9L tumors. Supporting our 
hypothesis, Prussian blue staining of the tumors showed that 9L4S tumors, which had the 
faster relaxation rates, had more iron deposits than the 9L tumors, which had the slower 
relaxation rates (Aim 3, Chapter 4). Taken together, the results obtained in the 
experiments described in Chapters 2-4 support the hypothesis that 9L4S cells are able to 
take up more iron because they express mms6 and because of the iron, 9L4S cells have a 
faster average relaxation rate.  
 
In molecular biology, recombinant DNA technology comprises a variety of laboratory 
techniques each used to manipulate DNA (89). Using these standard techniques, cells can 
be engineered to express any gene of one’s choosing. A cell is engineered to express a 
gene of interest in the hopes of giving that cell a novel trait or phenotype that it does not 
naturally possess. In the work presented in this dissertation, magA and mms6 were the 
genes whose putative functions in the magnetotactic bacteria made us consider them as 
potential iron-based MRI reporter genes (Figure 24). Even though the intracellular 
environment of the bacteria is distinct from that of the mammalian cell, 9L4S cell still 
gained a new phenotype, the ability to store more iron. Because it is a negative contrast 
agent, the iron altered the magnetization of the 9L4S cells such that they stood out from 
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because being a bacterial gene gives mms6 an advantage over other reporter genes 
because reporter genes work best if they are not naturally expressed in the organism 
being studied.  
 
Even though we have labeled mms6 as an MRI reporter gene based solely on the fact that 
cells expressing mms6 have faster relaxation rates than wild type cells, mms6 should be 
evaluated to gauge how useful it will be in more sophisticated studies. In the studies 
presented in this research, the 9L4S cells were always expressing mms6 and we knew 
exactly where to find them. To evaluate whether it can significantly increase the 
relaxation rates of cells when mms6 is not constitutively expressed, mms6 expression 
should be made dependent on the presence or absence of a particular molecular event. To 
detect a very specific molecular change, the experimental design would have to be 
sophisticated (6), which might prove to be a challenge; however, a sophisticated study 
that resulted in mms6 decreasing the relaxation rates of cells would substantiate the claim 
that mms6 is an MRI reporter gene. In addition, mms6 can be tested in a system where the 
cells of interest migrate to determine whether mms6 expression in migrating cells allows 
for the visualization of those cells. This last example may turn out to be a challenge 
because visualization of a small number of cells with MRI is difficult. One thing is clear, 
the more negative contrast mms6 is able to generate in vivo, the better a reporter gene it 
has the potential to be. 
 
Even before a more sophisticated approach is used, a few other experiments could be 
executed that would shed light on some unknowns. For starters, using a constitutively 
active vector like we have done leaves room for doubt about whether it is actually mms6 
causing the changes in relaxation rates and intracellular iron levels that we observed. 
These changes could have also been caused by a mutation brought about by the random 
insertion of the gene into the host cell’s genome. Because we created many clones which 
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all showed some change in relaxation rate, the chances that it was not mms6 that brought 
about the chances we observed in our experiments is unlikely. Regardless, it would be 
nice to know with certainty. To confirm that mms6 expression causes cells to uptake 
more iron and increases their relaxation rates, mms6 could be cloned into an expression 
vector containing a simple inducible promoter. By turning off gene expression and 
observing that the changes in intracellular iron and relaxation rates no longer occur, the 
function of mms6 as an MRI reporter gene would be validated. As another potential 
experiment, it would be interesting to determine whether recombinant protein Mms6 
binds iron like Mms6 does in the magnetotactic bacteria. Immobilized Metal Affinity 
Chromatography could potentially be used to both isolate the recombinant protein (which 
contains a His-tag) and to examine whether Mms6 binds iron. As a final experiment, the 
animal studies could be repeated using a range of different cell numbers to try and 
determine how large the tumor must be before the relaxation rate of the 9L4S is slower 
than the relaxation rate of the 9L4S tumor.  
 
As an iron-based MRI reporter gene, mms6 comes with several limitations. Even though 
mms6 altered the image contrast produced by subcutaneous mms6-positive tumors, it 
should be pointed out that mms6-positive cells would be less likely to stand out if they 
were located in an inhomogeneous tissue such as the abdomen. Even if mms6-positive 
cells were growing in a homogenous tissue, imaging of those cells using MRI signifies 
that detection of just a few cells may be difficult. We successfully detected differences in 
the MRI signal produced by mms6-positive cells, but the MRI signal was produced by a 
large grouping of cells that formed tumors that were at least 1.2 mm across in any 
dimension. Furthermore, our in vivo results suggest that there is also an upper threshold 
above which mms6-positive cells no longer have faster relaxation rates than control cells. 
In practice, perhaps this fact can somehow be used as an advantage. Regardless of the 
number of cells being imaged, mms6-positive cells need to have access to an iron pool in 
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order to function as an MRI reporter gene. In our animal studies, we saw evidence of 
angiogenesis in the dissected tumors, so we presume that the iron taken up by the tumor 
cells came from the blood supply. Our in vitro data leads us to believe that the iron pool 
would require a minimum amount of iron per unit volume in order to decrease the 
relaxation rate of the local mms6-positive cell population. Our in vivo data leads us to 
believe that the iron pool would not need to be highly concentrated with iron as long as 
the iron was periodically replenished. Once the cells were ready to be imaged, the 
detection of iron using MRI is usually limited to T2/T2*-weighted MRI imaging. In 
short, an mms6-based MRI reporter is best suited for the study of a group of cells 
growing in homogenous tissue with access to an iron supply.  
 
Though today MRI is mostly used in the clinical setting to detect and locate tumors, MRI 
may one day help visualize the expression and activity of various molecules, cells, and 
biological processes (90). Although still in the early stages of research and development, 
MRI reporter genes have the potential to become invaluable tools, capable of modulating 
NMR signal in response to biological events at the molecular level. We hope our research 
contributes to the field of molecular MRI by getting us one step closer to discovering a 










Because we worked with mammalian cell lines, which can potentially carry bloodborne 
pathogens, the research protocols presented in this dissertation were reviewed and 
approved by the Emory Health and Safety Office (EHSO) before any work with 
recombinant genes and proteins commenced. The experiments were conducted in a 
biosafety level II laboratory at Emory University and universal biosafety precautions 
were used.  
 
A.2. Animal Use 
 
Because we worked with animals, the research protocols presented in this dissertation 
were reviewed and approved by Emory University’s Institutional Animal Care and Use 
Committee (IACUC) before any work with the animals began. The experiments were 
conducted in an animal biosafety level II procedure room in an Emory University animal 
facility. As part of the IACUC approval process, we reduced the number of animal that 
were used in our research as much as possible and refined the proposed methods to limit 
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